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ABSTRACT
Cells are continuously exposed to a variety of physiological and environmental
stresses that can lead to protein aggregation and/or denaturation, and eventually cell
death.  In order to ensure survival, cells have evolved a stress response that monitors,
detects, and responds to changes within the cellular environment.  The stress response
is characterized by the up-regulation of heat shock protein (hsp) genes whose products
can mediate the assembly and/or degradation of misfolded or aggregated proteins
within the cell.  This stress-induced upregulation of heat shock protein encoding genes
is under the regulation of heat shock transcription factor 1 (HSF1) and its associated
proteins that together form what is known as the HSF1 heterocomplex.  In eukaryotic
cells, HSF1 exists as a non-DNA binding monomer in the absence of stress.  Upon
exposure to stress, HSF1 undergoes trimerization and acquires the ability to bind heat
shock elements (HSEs) located upstream of all hsp genes and after further modification,
can become converted into a transcriptionally active form.  Following prolonged stress
or after removal of stress, HSF1 loses its ability to bind DNA and transcription ceases
in a process termed attenuation.
Several studies have suggested that the DNA-binding and transcriptional activities
of HSF1 are regulated by phosphorylation and dephosphorylation events and by
chaperone-based folding mechanisms similar to those involved in the regulation of
glucocorticoid receptors.  Protein phosphatase 5 (PP5) has been identified as a member
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         of the glucocorticoid receptor chaperone complex and its phosphatase activity has been
shown to regulate the maturation and activation of the receptor.  It has been suggested
that PP5 may regulate HSF1 in a manner similar to that of glucocorticoid receptors
however it has not yet been determined how PP5 interacts with the HSF1
heterocomplex or if PP5 functions to regulate HSF1-DNA binding and/or HSF1
transactivation.
Utilizing the Xenopus model system, I tested the hypothesis that PP5 regulates the
DNA binding and transcriptional activities of HSF1 through interactions with the HSF1
heterocomplex.  Increasing the activity of PP5, either through the elevation of PP5
protein levels or by activating endogenous PP5, resulted in decreased HSF1-DNA
binding as well as accelerated attenuation after the removal of stress.  Conversely,
inhibiting the phosphatase activity of PP5 using okadaic acid or by immunotargetting,
where an antibody recognizing PP5 was microinjected into the nuclei of oocytes,
resulted in delayed HSF1 attenuation.  Transcription assays performed using activated
PP5 also demonstrated that PP5 acts to decrease HSF1-mediated transcription.
Immunoprecipitation and gel mobility supershift assays were also used to show that
PP5 interacts with the HSF1 heterocomplex and PP5-HSP90 binding mutants illustrated
that PP5 may exert its repressive effects independently of binding directly to HSP90.
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11.0  INTRODUCTION
1.1 The Stress Response
F. Ritossa first detected the stress response in 1962.  After applying heat shock to
the salivary gland cells of the fruit fly Drosophila buschii, Ritossa noted a new pattern
of “puffing” within the polytene chromosomes (Ritossa, 1996).  It has since been
discovered that this puffing was a response elicited by the cell to increase the
expression of specific genes encoding proteins that are needed to repair cellular
constituents damaged by the stress of heat shock (Lindquist, 1986; Lindquist and Craig,
1988).  Further studies have revealed that the stress response is activated by various
physiological, environmental, and chemical stresses such as elevated temperatures,
bacterial or viral infection, inflammation, ischemia, and exposure to toxic chemicals.
Stress response proteins are also expressed under non-stress conditions including
development and differentiation (Craig et al, 1993; Georgopolous and Welch, 1993;
Parsell and Lindquist, 1993; Lis and Wu, 1993; Morimoto, 1993; Wu, 1995; Hartl,
1996).  Under these conditions, proteins within the cell may unfold, misfold, or
aggregate, causing the cell to function improperly.  In order to counteract this effect and
ensure cellular survival, cells have evolved a stress response that detects and responds
to changes within the cellular environment.  A cell exposed to stress will increase the
2expression and synthesis of a family of cytoprotective proteins called heat shock
proteins (HSPs).
HSPs function as molecular chaperones during both steady state and stressful
conditions, and assist in the trafficking and folding of nascent polypeptide chains.
Conversely, HSPs are also involved in the degradation of proteins that have become
denatured or have been folded incorrectly.  HSPs have been highly conserved
throughout evolution and are arranged into five families based on molecular mass:
small HSPs (sHSPs), HSP60, HSP70, HSP90, and HSP100 (as reviewed by Glover and
Tkach, 2001, and Voos and Rottgers, 2002).  sHSPs range in size from 15-30 kDa.
They function to suppress the aggregation of proteins and assist in the folding of
proteins in an ATP-independent manner.  HSP60 also mediates the folding of proteins
but does so in an ATP-dependent manner.  HSP100 had been implicated in the
prevention of and re-solubilization of protein aggregates under stress conditions.
HSP70 and HSP90 family members have been found to be directly involved in the
regulation of the stress response.
HSP expression is under the control of a family of transcription factors called heat
shock transcription factors (HSFs).  HSFs bind to heat shock elements (HSEs) located
in the promoter region upstream of all HSP genes (Ananthan et al., 1986; Lis and Wu,
1993; Morimoto, 1993).  Four distinct HSFs have been identified: HSF1, HSF2, HSF3,
and HSF4.  HSF1 has been shown to play an important role in development, however
most research involving HSF1 has been centred around its involvement in the rapid
transcriptional upregulation of HSP genes (Xiao et al., 1999; Christians et al., 2000;
Pirkkala et al., 2001).  It is known that in unstressed cells HSF1 exists as a
3transcriptionally inert monomer that is unable to bind DNA.  Upon exposure to stress,
HSF1 trimerizes, becomes competent to bind DNA and gains the potential to induce the
transcription of hsp genes.  Following the removal of stress, HSF1 dissociates back into
its monomeric form and is again incapable of binding DNA, a process known as
attenuation.  HSF2 is considered to be the nonstress-inducible member of the HSF
family and is activated in response to signals associated with development and
differentiation (Sistonen et al., 1992; Xiao et al., 1999).  Relatively little is known
about the regulation of HSF2.  However, a recent study has shown that it becomes
inactivated in cells exposed to heat shock (Mathew et al., 2001).  The authors suggest
that heat shock proteins upregulated as a result of HSF1 transactivation may act to
negatively regulate the transcriptional activities of HSF2.  HSF3 has also been shown to
be responsible for the stress-inducible up-regulation of HSP genes, although unlike
HSF1 which has been identified in several species, HSF3 is unique to avians (Sarge et
al., 1993, Nakai and Morimoto, 1993; Nakai et al., 1995).  The activation/deactivation
mechanisms of HSF3 are similar when compared with HSF1, except that HSF3 exists
as a dimer in its inactive state rather than as a monomer.  As well, HSF3 is activated
under more extreme stress conditions such as severe heat shock, and attenuation
appears to be somewhat more delayed (Nakai 1999; Tanabe et al., 1998; Pirkkala et al.,
2001).  The most recently identified member of the HSF family is HSF4 (Nakai et al.,
1997).  Due to alternative mRNA splicing, there are two HSF4 isoforms (HSF4a  and
HSF4 b ) with contrasting functions (Tanabe et al., 1999).  HSF4 b , in a similar fashion
to that of HSF1, has been shown to function as a transcriptional activator of genes
encoding HSPs.  Conversely, HSF4 a  acts to inhibit HSF1-mediated transcription by
4interacting with and binding to the HSE; transcription does not occur as the HSF4a
isoform lacks a transcriptional activation domain (Nakai et al., 1997; Nakai 1999;
Tanabe et al., 1999; Zhang et al., 2001; Frejtag et al., 2001).
1.2 Heat Shock Factor 1(HSF1)
It has been well established that HSF1 is the major heat shock transcription factor
involved in regulating the stress-inducible expression of HSP genes.  The resultant
nascent HSPs are available to stabilize aggregated or denatured proteins, thereby
ensuring cellular survival.  HSF1 has been studied intensively and although much is
known about its structure and function, the mechanisms leading to HSF1 activation and
regulation have yet to be fully elucidated.
1.2.1 HSF1 Function
Under non-stress conditions, HSF1 exists as a monomer and it was once believed
to be located primarily within the cytoplasm (Baler et al., 1993; Sarge et al., 1993).
Recent evidence however suggests that HSF1 is located in both the cytoplasm and the
nucleus (Orosz et al., 1996).  Interestingly, HSF1 in Xenopus oocytes resides entirely in
the nucleus (Mercier et al., 1997).  Upon exposure to stress, HSF1 trimerizes (Baler et
al., 1993; Sarge et al., 1993) and acquires the ability to bind the conserved 5’-nGAAn-
3” pentanucleotide repeat found in HSEs located upstream of all heat shock genes (Wu,
1995; Morimoto, 1998; Morano and Thiele, 1999).  However, binding of HSF1 to the
5HSE is not sufficient to induce the transcription of HSP-encoding genes.  For example,
it has been shown in S. cerevisiae that HSF1 is bound constitutively to the HSE and that
further conformational changes are required before transcription is initiated in response
to stress (Sorger et al., 1987; Sorger and Pelham, 1988; Jakobsen and Pelham, 1988).
Certain chemical stressors such as salicylate are also known to induce DNA binding but
do not activate transcription in mammalian cells.  It therefore appears that HSF1 must
undergo further modifications before becoming transcriptionally active (Jurivich et al.,
1992; Lee, et al., 1995).  After the removal of stress, HSF1 becomes deactivated by
dissociation into monomers and the transcription of HSP genes ceases (Clos et al.,
1990; Nakai et al., 1993).  Studies utilizing tissue culture cells have also shown that
HSF1 transcriptional activity ceases when a cell is exposed to a prolonged stress.  HSF1
reverts to the monomeric state and becomes unable to bind DNA in a process referred
to as attenuation (Clos et al., 1990; Rabindran et al., 1991; Nakai et al., 1993).
Interestingly, studies involving Xenopus oocytes have shown that although the oocyte
retains the mechanisms to undergo attenuation, HSF1 remains bound to the HSE during
prolonged stress treatments and attenuation occurs only after cessation of stress-
treatments (Gordon et al., 1997; Bharadwaj, S et al., 1999).
1.2.2 HSF1 Structure
The structure of HSF1 has been highly conserved across various species of plants
and animals (Sorger and Pelham, 1988; Wiederrecht, et al., 1988; Clos, et al., 1990;
Scharf, et al., 1990; Sarge, et al., 1991; Nakai and Morimoto, 1993; Treuter et al.,
61993; Nover et al., 1996; Nakai et al., 1997).  HSF1 contains 2 hydrophobic heptad
repeats (HR-A/B and HR-C) and has 3 major domains: the DNA binding domain
(DBD), the regulatory domain (RD), and the transcriptional activation domain (TAD)
(Appendix 1).
The helix-turn-helix DNA binding domain (Damberger et al., 1994) is located
near the N-terminus of HSF1 and binds the HSE located upstream of all HSPs genes
(Wu, 1995; Morimoto, 1998; Morano and Thiele, 1999).  The regulatory domain is
located within the central region and contains serine/threonine residues that can be both
constitutively and inducibly phosphorylated.  This domain has been shown to play an
important role in determining the transactivation potential of HSF1 (Hensold et al.,
1990; Sarge et al., 1993; Cotto et al., 1996; Kline and Morimoto, 1997; Chu et al.,
1998; Holmberg et al., 2001; Soncin et al., 2003).  The transcriptional activation
domain (TAD) is located at the C-terminus of the HSF1 molecule and (Green et al.,
1995; Zuo et al., 1995) it appears to be regulated by the regulatory domain (Hoj et al.,
1994; Green et al., 1995; Shi et al., 1995; Zuo et al., 1995).  The TAD is not
particularly well conserved between species (Goodson et al., 1995; Green et al., 1995;
Newton et al., 1996).  There are two hydrophobic heptad repeats within the HSF1
protein.  The HR-A/B heptad repeat, adjacent to the N-terminal DNA binding domain,
contains leucine zipper motifs that are important for the trimerization of HSF1 (Sorger
and Nelson, 1989; Clos et al., 1990; Peteranderl and Nelson, 1992; Rabindran et al.,
1993; Harrison et al., 1994).  The HR-C heptad repeat is found adjacent to the
transactivation domain and is believed to negatively regulate the trimerization of HSF1
by interacting intramolecularly with the HR-A/B region (Rabindran et al., 1993).  This
7region is absent in HSF4 and is not well conserved in plants (Scharf et al., 1990; Nakai
and Morimoto, 1997).  Budding yeast also lacks the HR-C repeat which may explain
why S. cerevisiae HSF is constitutively trimerized (Jakobsen and Pelham, 1988).
1.2.3 HSF1 Regulation
When a cell is exposed to stress, HSF1 monomers trimerize and become
competent to bind DNA.  However, binding of HSF1 to DNA does not alone result in
the transcription of hsp genes (Clos et al., 1990; Rabindran et al., 1991; Sarge et al.,
1991, 1993; Baler et al., 1993).  A great deal of evidence suggests that the
trimerization/DNA binding and transcriptional activation of HSF1 are uncoupled and
may be regulated through different means.  It has been shown in cell types other than S.
cerevisiae that HSF1 is unable to bind the HSE until it has undergone trimerization.
The formation of HSF1 trimers is dependent on two hydrophobic heptad repeats (HR-
A/B and HR-C) located within the HSF1 molecule (Sorger and Nelson 1989; Clos et
al., 1990; Peteranderl and Nelson, 1992; Rabindran et al., 1993; Harrison et al., 1994).
During non-shock conditions, the HR-C heptad region is bound to the HR-A/B region,
and acts to suppress trimerization (Rabindran et al., 1993; Orosz et al., 1996; Farkas et
al., 1998).  In order for trimerization to occur, the HR-C region separates from HR-
A/B, exposing the HR-C region.  HSF1 monomers are then able to interact through
their HR-A/B repeats and do so forming a three stranded coiled-coil domain (Sorger
and Nelson, 1989; Peteranderl and Nelson, 1992).  The resulting coiled-coil domain
8acts to orient the three DNA binding domains, allowing the HSF1 homotrimer to bind
the HSE (reviewed by Ahn et al., 2001).
The mechanism by which HSF1 senses stress is poorly understood.  However,
recent evidence suggests that a loop within the helix-turn-helix DNA binding domain
(DBD) is essential for sensing heat shock and stabilizes intermolecular interactions
between the HSF1 trimers.  In vitro studies have shown that the DBD loop undergoes a
conformational change in response to stress.  As intramolecular interactions are
weakened, the trimerization domain becomes exposed and trimerization is enhanced
(Ahn et al., 2001).
In addition to intrinsic regulation, extrinsic mechanisms have been shown to
regulate the DNA binding and transcriptional activities of HSF1.  For example, HSP90
and HSP70 are molecular chaperones known to regulate HSF1.  Pharmacological
inhibition or artificial reduction in levels of HSP90 have been shown to enhance the
DNA binding and transcriptional activation of HSF1 (Ali et al., 1998; Zuo et al., 1998;
Bharadwaj, S et al., 1999).  Several studies support the idea that HSP70 acts as a
negative regulator of HSF1.  For example, Abravaya et al. (1992) found that during
heat shock, HSP70 binds to HSF1 and acts to enhance the attenuation phase of the heat
shock response.  Similarly, other studies have shown that overexpressed HSP70
negatively regulates HSF1 transcriptional activity by binding to the transactivation
domain (Baler et al., 1992; Mosser et al., 1993; Rabindran et al., 1994; Shi et al.,
1998).  These results suggest that HSPs upregulated by the stress response act to
regulate the activities of HSF1 in a negative feedback loop manner.
9Recently an additional protein, heat shock factor binding protein 1 (HSBP1), has
been found to bind HSF1 and regulate both DNA binding and transcriptional activities.
In vivo experimentation has demonstrated that HSBP1 binds the HR-A/B repeats in
trimers as HSF1 becomes competent to bind DNA (Satyal et al., 1998; Tai et al., 2002).
During the attenuation phase of the heat shock response, newly synthesized HSP70
binds HSBP1, mediating the conversion of HSF1 trimers into inactive monomers
(Satyal et al., 1998).  In vitro studies have also shown that overexpression of HSBP1
decreases the DNA binding and transcriptional activities of HSF1, indicating that
HSBP1 acts as a negative regulator of HSF1 (Satyal et al., 1998).  Interestingly,
attenuation of HSF1 was not observed in the presence of HSBP1 under severe heat
shock conditions where HSP gene expression was not induced. This further suggests
that HSP70 is required for proper HSF1 disassembly (Satyal et al., 1998).
Recently, two ubiquitin-like proteins, small ubiquitin-related modifier 1 and 2
(SUMO-1 and SUMO-2) have been identified as regulators of HSF1 activity (Hong et
al., 2001; Hilgarth et al., 2003; Hietakangas et al., 2003).  Sumoylation of HSF1
involves the covalent linkage of SUMO-1 or SUMO-2 proteins on lysine residues.  As a
result, HSF1 undergoes a conformational change allowing HSF1 to bind the HSE.  The
mechanisms underlying HSF1 regulation through sumoylation have not been
extensively studied, but the following model has been put forth to explain the mode of
action.  New evidence suggests that HSF1 becomes inducibly phosphorylated within
the regulatory domain on serine 303/307 residues (Hietakangas et al., 2003).  This
causes HSF1 to undergo a conformational change, permitting sumoylation at lysine
residue 298.  It is believed that the sumoylation of lysine 298 promotes dissociation of
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the HR-A/B and HR-C domains and subsequent trimerization (Hong et al., 2001;
Hietakangas et al., 2003; Hilgarth et al., 2003).  It has also been suggested that further
stress-inducible sumoylation positively regulates transactivation (Hong et al., 2001).
The mechanisms underlying this transcriptional regulation, apart from DNA binding
activities, remains controversial and unclear.
It has long been suggested that phosphorylation and dephosphorylation events
play a pivotal role in the regulation of HSF1.  Both the transcriptionally active and
inactive forms of HSF1 are known to be heavily phosphorylated, however the role of
phosphorylation in the regulation of HSF1 is complex and not well understood.  Initial
studies suggested that HSF1 remained transcriptionally inert through constitutive
phosphorylation and that hyperphosphorylation was required for transcriptional
activation (Sorger et al., 1987; Sorger and Pelham, 1988; Baler et al., 1993; Sarge et
al., 1993).  Jurvich et al. (1992) examined different forms of stress and observed the
effects on HSF1.  It was shown that cells tested with the anti-inflammatory drugs
indomethacin and sodium salicylate activated HSF1 DNA-binding but not
transactivation (Jurvich et al., 1992; Lee et al., 1995).  Cotto et al., (1996) performed
similar stress experiments but in addition focused on tryptic digests and phosphopeptide
mapping.  These studies revealed that the transcriptionally active form of HSF1 found
in heat shocked HeLa cells was more heavily hyperphosphorylated then HSF1 in cells
treated with indomethacin or salicylate.  Subsequent studies have since produced
evidence supporting the hypothesis that HSF1 must undergo additional phosphorylation
to become transcriptionally active.  Xia and Vollmey (1997) observed that HSF1
transactivation was reduced in heat shocked HeLa cells treated with serine/threonine
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kinase inhibitors, and conversely, that transactivation was enhanced in cells treated with
phosphatase inhibitors.  They performed tryptic digests and repeatedly found four
serine/threonine residues that became hyperphosphorylated during heat shock (Xia and
Vollmey, 1997).
Although there appears to be a link between phosphorylation and HSF1 activity, it
has proven relatively difficult to characterize the specific residues targeted for both
constitutive and inducible phosphorylation.  Recent research has identified residues that
are inducibly phosphorylated and are required for the full activation of HSF1
transcriptional activity.  Holmberg et al., (2001) identified a specific phosphorylation
site on HSF1 that promotes stress-induced transactivation.  Using specific
phosphopeptide antibodies, they have shown that serine 230 is phosphorylated after
heat shock, that this phosphorylation event is required for HSF1 transactivation, and
that substitution of this site results in a reduction of HSP gene expression (Holmberg et
al., 2001).  More recently, in vitro experiments and phosphopeptide mapping suggest
that threonine 142 becomes phosphorylated when HSF1 is incubated with casein kinase
2 (CK2) (Soncin et al., 2003).  Mutational analysis has shown that the phosphorylation
of threonine 142 is necessary for transactivation and is required for efficient binding of
HSF1 to the HSE (Soncin et al., 2003).  Another recent study using phosphoantibodies
identified serine 303 and 307 as sites that are inducibly phosphorylated after heat
shock.  Phosphorylation at this site has also been shown to positively regulate HSF1
transactivation (Hietakangas et al., 2003).
It is now quite evident that phosphorylation is required for HSF1 transcriptional
activation.  However, the issue of phosphorylation is rather complex since constitutive
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or inducible phosphorylation of specific serine residues within the TAD of HSF1 may
act to repress its transcriptional activities.  Studies using tissue culture cells and
Xenopus oocytes have shown that phosphorylation of HSF1 on serine 303, 307, and 363
residues represses transcription (Chu et al., 1996 and 1998; Kline and Morimoto, 1997;
Xavier et al., 2000).  Kline and Morimoto (1997) have demonstrated, using mutational
analysis, that HSF1 remains transcriptionally inert when serines 303 and 307 are
constitutively phosphorylated under stress conditions and may offer an explanation as
to why HSF1 remains transcriptionally inactive under non-shock temperatures.  Chu et
al., (1996 and 1998) suggested that transcriptional repression of HSF1 is partly
regulated through a series of protein kinase cascades.  In vitro and in vivo studies using
transcriptional assays and kinase overexpression, have shown that the transactivation of
HSF1 is repressed when serine 307 is phosphorylated by mitogen activated protein
kinases (MAPKs) prior to serine 303 phosphorylation by GSK3 b  (Chu et al., 1996).
Similar in vitro experiments also showed that phosphorylation of serine 363 by protein
kinase C (PKC) represses HSF1 transcriptional activity (Chu et al., 1998).  However,
these authors mentioned that in vivo experiments inhibiting PKC activity did not
markedly enhance transactivation, suggesting that PKC may play a less prominent role
in regulating HSF1 transcription activation than GSK3b  and MAPKs.  Although these
studies offer an explanation for the sequence of phosphorylation, the mechanisms
involved in the repression or activation of HSF1 transactivation remain unclear.
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1.3  Protein Phosphatase 5 (PP5)
Although the details are unclear, it is generally agreed that a number of
phosphorylation events are involved in the regulation of HSF1.  Phosphorylation has
been shown to both negatively and positively regulate the transcriptional and DNA
binding activities of HSF1.  However, little is known about how and what protein
phosphatases may regulate the activities of HSF1.  Ding et al., (1998) have shown that
protein phosphatases PP1 and PP2A have elevated activity in cells overexpressing
HSP70 and it has been speculated that PP1 and PP2A may act to dephosphorylate
HSF1 and negatively regulate its transcriptional activity.  As well, Guo et al., (2001)
presented evidence suggesting that the protein phosphatase PP5 may interact with
HSF1, but it has not yet been determined if PP5 functions to regulate the DNA binding
and transcriptional activities of HSF1.
PP5 has been identified as a member of the phosphoprotein phosphatase (PPP)
family along with the protein phosphatases PP1, PP2A, PP2B, PP2C, PP4, PP6, and
PP7 (Becker et al., 1994; Chen et al., 1994; Chinkers et al., 1994).  Due to low protein
levels and low basal phosphatase activity in many cells, PP5 has gone relatively
undetected.  Within the past nine years, the function, structure, and regulation of PP5
has begun to be elucidated.
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1.3.1  PP5 Structure
The reversible phosphorylation of proteins by phosphatases is critical in the
regulation of a wide variety of biological processes including metabolism, signal
transduction, and cell cycle progression.  As a result, phosphatases, including PP5, have
been highly conserved across several species.  PP5 has been identified as both a
cytoplasmic and nuclear protein in all cell types examined to date (Becker et al., 1994;
Chen et al., 1994; Chinkers et al., 1994; Cohen, 1997; Chinkers, 2001; Dobson et al.,
2001).
The phosphatases have traditionally been grouped into five sub-families (PP1,
PP2A (which includes PP4 and PP6), PP2B, PP5, and PP7) that are partially based on
their sequence and biochemical properties (Cohen, 1997; Huang et al., 1998; Zuo et al.,
1998).  PP5, unlike the other members of the PPP family, is unique in that it does not
contain separate catalytic and regulatory subunits.  The subcellular localization signal,
enzymatic activity, substrate specificity, and regulatory domains of PP5 are all
contained within a single polypeptide chain (Chen et al., 1994; Chinkers et al., 1994).
PP5 is a 58 kDa protein composed of 499 amino acids and contains 5 major
domains; a catalytic domain (CD), a regulatory domain (RD), and 3 tetratricopeptide
(TPR) domains (see Appendix 2).
The catalytic domain, also known as the phosphatase domain, is centrally located
and closely related to the catalytic subunits of PP1, PP2A, and PP2B, as the amino acid
sequences in the respective catalytic regions are 42-43% identical (Barton et al., 1994;
Chinkers, 2001).
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The regulatory domain of PP5 is located at the extreme C-terminus of the peptide
and is believed to have an autoinhibitory function (Chen and Cohen, 1997; Sinclair et
al., 1999; Kang et al., 2001; Ramsey and Chinkers, 2002).  This domain interacts with
the N-terminal TPR domains and prevents the access of substrate proteins to the
catalytic domain, thereby inhibiting phosphatase activity.  Upon binding with an
activator or substrate, the regulatory and TPR domains separate, thus exposing the
phosphatase domain and relieving any inhibition (Chen and Cohen, 1997; Sinclair et
al., 1999; Kang et al., 2001).
Another unique feature of PP5 is that it possesses three TPR domains located near
its N-terminus (Chen et al., 1994; Chinkers et al., 1994; Fukuda et al., 1996).  The TPR
domains of PP5 belong to a family of heat shock protein 90 (HSP90)-binding TPR
domains (Chinkers, 1994; Chinkers et al., 2001).  The crystal structure of the PP5 TPR
domains have recently been characterized (Das et al., 1998).  Each domain is virtually
identical in structure, containing a pair of antiparallel a -helices.  The three TPR
domains align in a parallel fashion in an arrangement that creates an amphipathic
protein-binding groove (Das et al., 1998).  Three amino acid residues within the groove
(lysine 32, lysine 97, and arganine 101) are believed to be essential for the binding of
PP5 to HSP90 and other TPR containing proteins (Das et al., 1998; Russell et al., 1999;
Scheufler et al., 2000; Ramsey et al., 2000).  Although the TPR domains are required
for mediating protein-protein interactions, they also play an additional role in the
activation/deactivation of PP5.  In the absence of a substrate or activator, the TPR
domain binds to the regulatory domain of the PP5 molecule which acts to inhibit the
16
catalytic domain.  As the two domains separate, both become accessible allowing PP5
to bind substrates and initiate its phosphatase activity (Chinkers, 2001).
1.3.2  Regulation of PP5
As described above PP5, is composed of a single polypeptide chain with
autoregulated phosphatase activity.  Chen and Cohen (1997) described the
autoinhibitory regulation of PP5 after removing the N-terminal TPR domain and
observing a 25-fold increase in PP5 phosphatase activity.  From these studies it was
determined that the TPR domain acted to shield the active site of the catalytic domain.
It was also suggested that the catalytic domain was only inaccessible to larger
molecules as low basal activity of PP5 could still be detected.  Studies by Kang et al.,
(2001) have identified two amino acid residues that are required for PP5 autoinhibition.
Site-directed mutagenesis of PP5 was performed on several residues located within
both the N-terminal (TPR) and C-terminal (regulatory) domains.  It was determined that
glu-76 (within the TPR domain) and gln-495 (within the regulatory domain) are
necessary to maintain the autoinhibition of PP5.  Mutation of these residues increased
basal phosphatase activity by 10-fold over wild-type PP5 (Kang et al., 2001).  Although
glu-76 and gln-495 are important for autoinhibition, it was noted that mutation of these
residues did not result in the full activation of PP5, therefore suggesting that other
unidentified molecules/mechanisms may be involved in its regulation.
In order to better understand the biochemical and biological activities of PP5,
researchers have searched for potential activators and inhibitors of PP5.  Initial studies
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focused on treating purified full length PP5 enzyme with various agents that had
already been identified as inducers of general phosphatase activity.  These included
compounds such as protamine, spermine, ceramide, and arachidonic acid (Cohen, 1989;
Gong et al., 1992; Dobrowsky et al., 1993).  Polyunsaturated fatty acids, such as
arachidonic acid, linoleic acid, oleic acid, and linolenic acid were found to activate PP5
phosphatase activity.  However, the levels required to activate PP5 in vitro exceed
physiological concentrations (Chen and Cohen, 1996; Skinner et al., 1996).
Nevertheless, the mode of activation of PP5 by polyunsaturated fatty acids was partially
characterized using site directed mutagenesis and proteolysis (Chen and Cohen, 1996;
Sinclair et al., 1999; Kang et al., 2001).  Chen and Cohen (1996) showed that the fatty
acid component of phosphatidylinositol binds to the TPR domain of PP5 and
derepresses phosphatase activity.  Kang et al., (2001) discovered that asparagine 491
was required for arachidonic acid to bind and activate PP5.  Sinclair et al., (1999)
illustrated that removal of both the TPR and regulatory domains rendered PP5
unresponsive to arachidonic acid.  Together these results suggest that PP5 is activated
through releasing the autoinhibitory interactions between the N-terminal TPR and C-
terminal regulatory domains.
Although polyunsaturated fatty acids act as activators of PP5, in vitro activation
of phosphatase activity is only observed when fatty acids are present at
supraphysiological concentrations.  As a result, attempts have been made to find related
compounds that may act as physiological activators of PP5.  Previous research has
revealed that long-chain fatty acyl-CoA esters play a role in regulating gene expression
and signal transduction processes in vivo (Hertz et al., 1998; Black et al., 2000; Corkey
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et al., 2000).  This led to the hypothesis that long-chain CoA compounds may activate
PP5 phosphatase activity.  It was found that both unsaturated and saturated long-chain
fatty acyl-CoA esters activated PP5 (Ramsey and Chinkers, 2002).  Interestingly, not all
saturated fatty acid moieties activate PP5 and the specificity of PP5 to polyunsaturated
fatty acids is apparently due to the limited solubility of saturated compounds (Ramsey
and Chinkers, 2002).
Since PP5 activation was known to require separation of the C-terminal-
regulatory and N-terminal TPR domains, the next step was to identify proteins that bind
the TPR domain of PP5 and determine what effects they may have on PP5 activation
(Chen and Cohen, 1996; Sinclair et al., 1999; Kang et al., 2001).  Using yeast two-
hybrid analysis, Yamaguchi et al., (2002) identified two G proteins, Ga 12 and G a 13,
that bind PP5 and discovered that its phosphatase activity increased 2.5 fold when the
GTPase activity of these proteins was active.  The mechanisms of activation were not
determined, although it has been suggested that binding of G proteins to the TPR
domain alleviated the autoinhibition of PP5.  As PP5 contains a TPR domain that
belongs to the family of heat shock protein 90 (HSP90)-binding TPR domains, Ramsey
and Chinkers (2002) hypothesized that HSP90 may itself act as a physiological
activator of PP5.  Although native full-length HSP90 did not activate PP5 phosphatase
activity in vitro, the 12kDa C-terminal domain of HSP90 stimulated PP5 activity 10
fold.  The authors suggested that, although only the C-terminal region of HSP90
activated PP5 in vitro, full-length HSP90 may still act as a physiological activator of
PP5.  It was also suggested that the full-length HSP90 used in these experiments may
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have had to undergo additional conformational changes in order to decrease possible
steric hindrance by the amino-terminal region (Ramsey and Chinkers, 2002).
Additional studies focused on the identification of specific PP5 inhibitors.  This
has proven difficult as many of the known inhibitors act in a non-specific manner.
Nevertheless, okadaic acid, nodularin, and fostreicin have been identified as potent
inhibitors of PP5 when used within a specific concentration range.  The IC50 values of
okadaic acid, nodularin, and fostriecin for PP5 are 7nm, 2.5nm, and 700m m
respectively (Chen et al., 1994; Walsh et al., 1997; Borthwick et al., 2001).  However,
at higher concentrations, each of these components inhibit other members of the PPP
family such as PP1 and PP2A (Honkanen et al., 1991 and 1994; Walsh et al., 1997).
To date only one protein, the human blue-light photoreceptor cryptochrome2
(hCRY2), has been shown to specifically inhibit PP5 phosphatase activity (Zhao and
Sancar, 1997).  An interaction between the TPR domains of PP5 and hCRY2 was
discovered using yeast two-hybrid analysis.  Phosphatase assays showed that hCRY2
inhibits PP5 phosphatase activity by 75% when compared with the basal activity of PP5
however the mechanisms of inhibition have not yet been determined.
1.3.3  PP5 Function
Some of the published research on PP5 is beginning to focus on the identification
of novel PP5-protein interactions and on determining its effects on a variety of
substrates.  One of the first studies to identify PP5 used yeast-two hybrid screening with
the atrial natriuretic peptide receptor (ANP receptor) (Chinkers, 1994).  Although it was
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initially thought that there was direct interaction between PP5 and the ANP receptor, it
has since been discovered that the interaction was mediated by HSP90 (Kumar et al.,
2001).  To date however, only an interaction between the two proteins has been
established, and the effect of PP5 phosphatase activity on the regulation of the ANP
receptor has yet to be determined.
Recently another protein has been shown to interact with PP5 via HSP90.  The
heme-regulated inhibitor of protein synthesis (HRI) is a kinase that co-ordinates the
synthesis of globin with the availability of heme (as reviewed by Chen, 1993; Chen and
London, 1995; Shao et al., 2002).  HSP90 is known to associate with HRI intermediates
and is required for the maturation of the HRI complex (Uma et al., 1997; Shao et al.,
2002).  In order to further characterize the composition of the chaperone complex
associated with the HRI, immunoadsorptions were performed and the results identified
PP5 as a member of the HSP90-HRI complex.  Additional experimentation using
activators and inhibitors of PP5 confirmed that PP5 acts to negatively regulate HRI
maturation.  Thus HRI has been established as one of the few known substrates of PP5
(Shao et al., 2002).
The binding of PP5 to proteins via the TPR domain of HSP90 was initially
identified in studies involving glucocorticoid receptors (GRs) (Chen et al., 1996;
Silverstein, 1997) which, after binding hormone, translocate to the nucleus and regulate
the transcription of target genes.  GRs acquire the ability to bind hormone through
interactions with HSP90 heterocomplexes and must undergo conformational changes
needed for conversion to a hormone binding form.  The process of maturation involves
the sequential binding and release of several proteins.  Initially, HSP70, HSP70
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interacting protein (HIP), and HSP40 interact with the non-hormone binding form of
the receptor (Dittmar et al., 1998; Kosano et al., 1998).  The HSP90-HSP70 organizing
protein (HOP) then mediates the binding of an HSP90 dimer to HSP70 and the
immature steroid receptor forming an intermediate complex (Johnson et al., 1998;
Prodromou et al., 1999).  Finally HSP70, HIP, and HSP40 dissociate from the HSP90-
steroid receptor complex, allowing the binding of p23 and one of the immunophilins
FKBP51, FKBP52, or CyP-40 (Johnson et al., 1994 and 1998).  The receptor then
dimerizes and translocates into the nucleus where it is capable of binding hormone and
transcribing target genes.
HOP and the immunophilins associate with HSP90 via the TPR domain (Radanyi
et al., 1994; Chen et al., 1996; Owens-Grillo et al., 1996; Ratajczak and Carrello,
1996).  The interaction of PP5 with GR-complexes was confirmed with
immunoprecipitations that were performed using PP5 and HSP90 (Chen et al., 1996).
Further research showed, in vitro, that approximately 50% of GR-HSP90
heterocomplexes within the cytosol bind FKBP51 or FKBP52, 35% bind PP5, and an
undetermined fraction appears to bind CyP-40 (Silverstein, 1997).  To determine what
effects PP5 may have on GR regulation, Chen et al., (1996) went on to use a PP5
dominant negative mutant and showed that the inhibition of PP5 resulted in a decrease
GR-mediated transcription.  However, this data was contradicted by a more recent
study in which antisense oligonucleotides were used to suppress the expression of PP5.
Suppression of PP5 led to an increase in both DNA binding and GR-regulated
transcription suggesting that PP5 acts as a negative regulator of GR-DNA binding and
transcriptional activity (Zuo et al., 1999).  Additional research illustrated that the
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increase in DNA binding is related to the mechanism by which PP5 regulates the
nucleocytoplasmic shuttling of GRs.  Dean et al., (2001) showed that the suppression of
PP5 results in the nuclear accumulation of GRs and a consequent increase in GR-DNA
binding.  Further studies must be performed in order to determine exactly what effects
PP5 has on the regulation GR activities.
Yeast two-hybrid screening has also identified other proteins that interact with
PP5: protein phosphatase 2A (PP2A) (Lubert et al., 2001), apoptosis signal-regulating
kinase 1 (ASK1) (Morita et al., 2001), and the anaphase-promoting complex (APC)
(Ollendorff and Donoghue, 1997).  The interaction between PP5 and PP2A has been
confirmed in vivo using immunoprecipitation analysis.  However, the biological
purpose of this interaction has yet to be elucidated.
The apoptosis signal-regulating kinase 1 (ASK1) is a MAP kinase kinase kinase
that activates the JNK and p38 pathways in response to several forms of stress (Xia et
al., 1995; Kyriakis et al., 1996; Ichijo et al., 1997; Ono and Han, 2000; Davis, 2000;
Tobiume et al., 2001).  PP5 has been identified as a binding partner of ASK1 and was
shown to regulate ASK1 by dephosphorylating a phospho-threonine residue within the
activation domain of ASK1.  This dephosphorylation acts to inactivate ASK1 activity
suggesting that PP5 may function in an anti-apoptotic manner (Morita et al., 2001).
To identify cell cycle proteins with possible PP5 interactions, Ollendorff and
Donoghue (1997) performed a yeast two-hybrid screen.  It was determined that the
anaphase promoting complex (APC) interacts with and binds to PP5 (Ollendorff and
Donoghue, 1997).  The APC is a multisubunit complex composed of 13 subunits and is
required for sister chromatid segregation and exit from mitosis (Zachariae and
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Nasmyth, 1999; Harper et al., 2002; Hall et al., 2003).  Additional research has also
shown that phosphorylation of three of the thirteen subunits is required for APC
activation (Kotani et al., 1998; Rudner and Murray; 2000).  However, in vitro studies
have demonstrated that only two of the eight subunits, CDC16 and CDC27, bind to the
TPR domain of PP5 (Ollendorff and Donoghue, 1997).  Although an interaction
between PP5 and two subunits of the APC has been confirmed, it has yet to be
determined what effect the phosphatase activity of PP5 has on the regulation of the
anaphase-promoting complex.
p53 has also been identified as a protein that is regulated in part by PP5, although
an interaction between the two proteins has not been observed (Zuo et al., 1998).  It has
been demonstrated that by inhibiting PP5 expression using antisense oligonucleotides,
p53 becomes hyperphosphorylated resulting in an increase in p53 mediated
transcription (Zuo et al., 1998).  Specifically, the regulation of p21WAF/CiP1 by p53 was
investigated and it was determined that hyperphosphorylation of p53 due to the
inhibition of PP5 gene expression led to the induction of p21WAF/CiP1 and to G1 growth
arrest.  The authors suggest further investigation of PP5 inhibition may uncover the
potential to act in the treatment of cancer.  Interestingly, fostriecin, an inhibitor of
protein phosphatases at varying concentrations has been investigated in clinical trials
for use as an antitumour drug (de Jong et al., 1999).
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1.4  The Xenopus Oocyte Model System
The Xenopus oocyte is an excellent model system that offers unique opportunities
for research in both cell and developmental biology.  One of the benefits of the system
is that large numbers of oocytes can be easily extracted from the animal during a single
surgical procedure.  As well, oogenesis is continuous throughout the frog’s
reproductive cycle, therefore all stages of oocytes (I-VI) are accessible and readily
available at any given time.  Ovulation can also be induced or oocytes may be fertilized
in vitro to allow developmental studies with embryos.  Stage VI oocytes (used
throughout this thesis) are extremely large (1.3 mm in diameter) making manipulation
of the oocyte relatively simple.  For example, DNA, mRNA, and proteins can be
microinjected into the nucleus or cytoplasm of the oocyte with relatively little difficulty
(Gurdon et al., 1971; Gurdon and Wickens, 1983).  The nucleus can also be separated
intact from the cytoplasm allowing for studies to be carried out within isolated cellular
compartments (Gurdon and Wickens, 1983).  The oocyte has a large synthetic
capability possessing the same volume as 2x105 tissue culture cells with ability to
synthesize 20 ng of total RNA and 400 ng of total protein in one day (Gurdon and
Wickens, 1983).
Another benefit of the oocyte model system is that the stress response has been
well characterized.  Certain features of the response vary between the oocyte and tissue
culture models.  The major difference is that HSF1 within the oocyte does not undergo
the process of attenuation when exposed to ongoing heat stress.  Instead, HSF1 retains
its DNA binding activity until heat shock has been removed (Gordon et al., 1997;
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Bharadwaj, S et al., 1998, 1999).  It has also been determined that an increase in HSP
levels as a result of HSF1 transcriptional activation is not detectable in oocytes (Horrell
et al., 1987; King and Davis, 1987).  This is most likely due to the fact the oocyte
DNA/cytoplasm ratio is at least 10,000 times lower than in most cells.
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2.0  EXPERIMENTAL OBJECTIVES
It has been well established that HSF1 is the main transcription factor responsible
for the upregulation of HSP gene transcription during the heat shock response.
However, the mechanisms involved in the regulation of HSF1-DNA binding and
transcriptional activation remain largely unknown.  Recent studies have begun to
investigate the regulation of HSF1 by means of post-translational modification, more
specifically the effects of phosphorylation and sumoylation.  The hypothesis to be
tested here is that HSF1 is regulated by a protein phosphatase.  The present study
focuses on PP5, due to previous findings of HSP90 in HSF1 complexes and PP5 in
HSP90 complexes.
The aim of this study was to examine the effects of PP5 on both HSF1-DNA
binding and transactivation.  The approach taken was to 1) activate endogenous PP5 or
increase PP5 protein levels by microinjection of expression vectors, and 2) inhibit PP5
phosphatase activity using a potent inhibitor of PP5, okadaic acid.  Next I set out to
determine if PP5 interacts with HSF1. To accomplish this, immunoprecipitations and
gel mobility supershift assays were performed.
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3.0  MATERIALS AND METHODS
3.1  Oocyte Extraction
Xenopus laevis frogs were purchased from Xenopus I, Ann Arbor
Michigan.  Oocytes were surgically removed from frogs anaesthetized in 0.2%
(w/v) Tricaine.  Extracted oocytes were agitated in a calcium-free OR2 buffer
(82.5 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 1 mM NaH2PO4, 5 mM HEPES,
10 mg/L benzyl penicillin, 10 mg/L streptomycin sulphate ;Wallace et al., 1973)
containing 0.2% (w/v) collagenase for 3-4 hours until follicular cells were
removed.  After removal of follicle cells, oocytes were washed extensively and
placed in petri dishes containing OR2 (as above with 1 mM CaCl2 added).
Healthy stage VI oocytes were selected under a dissecting microscope and
staged according to Dumont (1972).  Oocytes were then kept in OR2 at 18
oC
until further experimentation.
3.2  Protein Extract Preparation
Following experimental treatments, oocytes were placed in 1.5 ml
microcentrifuge tubes and excess OR2 buffer was removed.  Buffer C (50 mM
Tris-HCl (pH 7.9), 50 mM KCl, 0.1 mM EDTA (pH 8.0), 20% (v/v) glycerol, 2
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mM dithiothreitol, 10 m g/ml aprotinin, 10 m g/ml leupeptin ;Dignam et al., 1983)
was added to microcentrifuge tubes at a final volume of 10 m l per oocyte.
Samples were homogenized using a micropipetter and centrifuged at 15,000xg
for 5 min (4oC).  The supernatant was removed and transferred to a new
microcentrifuge tube and stored at -80oC.  Extracts from oocytes injected with
CMV-CAT or hsp-70 plasmids were made using 10 m l per oocyte 0.25 mM
Tris-HCl (pH 7.5) containing aprotinin and leupeptin instead of Buffer C
(Landsberg et el., 1995).  All oocyte extracts were stored at –80oC.
Nuclear and cytoplasmic extracts were made as follows.  After
experimental treatments, oocytes were scored on the centre of the animal pole
with Dumont No. 5 forceps.  Oocytes were then gently squeezed with the
forceps, forcing out the nucleus.  The remaining contents of the oocyte (minus
the nucleus) were retained for cytoplasmic extracts.   Nuclear and cytoplasmic
fractions were transferred to separate 1.5 ml microcentrifuge tubes and excess
OR2 buffer was removed.  2 m l of Buffer C was added per nuclei and 10 m l was
added per cytoplasmic fraction.  The nuclear-buffer/cytoplasmic-buffer
mixtures were homogenized and centrifuged as above and the samples were
stored at –80oC.
3.3  Stress treatments
Stage VI oocytes were exposed to various stressors and treatments.  For
heat shock, oocytes were placed in sealed petri dishes containing pre-warmed
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OR2 buffer and immersed in a 33oC water bath for times indicated in the
figures.  For recovery experiments, oocytes were heat shocked as above,
removed from the 33oC water bath and allowed to recover at 18oC for 0, 5, 15,
30, and 60 minutes.  As a control for each experiment, unshocked oocytes were
incubated in OR2 buffer and kept at 18oC.  For chemical stresses, chemicals
were diluted directly into the OR2 buffer (18
oC) to yield the final required
concentrations (Gordon et al., 1997).  After stress treatments, oocytes were
rinsed and placed in fresh OR2 buffer and allowed to recover at 18oC until
extracts were made (as indicated in the figures).
3.4  Antibodies and Enzymes
Antibodies used in this thesis are as follows: polyclonal anti-HSP90 (gift
from S. Hartson and B. Matts, Oklahoma State University, OK.), polyclonal
anti-PP5 (gift from M. Chinkers, University of South Alabama, AB.),
monoclonal anti-p23 (clone JJ3 ;gift from D. Toft, Mayo Graduate School,
MN.), polyclonal antibodies anti-FKBP52 (clone Hi52c), anti-Hip (clone 2G6),
and anti-Hop (clone f5 ;gift from D. Smith, University of Nebraska, NE.),
polyclonal anti-HSF1 (gift from S. Fox, Northwestern University, IL.),
polyclonal anti-PP1 (539517-Calbiochem), polyclonal anti-PP2A (05-421-
Upstate Biotech.), monoclonal anti-Ik B (sc-1643), polyclonal anti-YY1 (sc-
372G), monoclonal anti-PCNA (sc-56 ;Santa Cruz Biotechnology, Santa Cruz,
CA.), and horseradish peroxidase-conjugated goat anti-rabbit and goat anti-
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mouse immunoglobulin G (BioRad).  Enzymes used for microinjection were
PP1 (539527-Calbiochem) and PP2A (539508-Calbiochem).
3.5  Fostriecin and Okadaic Acid Treatments
Fostriecin was purchased from Calbiochem and okadaic acid was
purchased from Sigma.  Fostriecin was dissolved in H2O and okadaic acid was
dissolved in dimethyl sulfoxide (DMSO) (1:500 v/v).  In all experiments,
oocytes were pretreated for 2 hours at 18oC in OR2 buffer containing 4 m M of
fostriecin or 100 nM of okadaic acid and then heat shocked at 33oC for times
indicated in the figures.  For controls, oocytes were pretreated at 18oC for 2
hours in OR2 containing DMSO at a dilution of 1:500 (v/v) and heat shocked as
described above.
3.6  Microinjections
Stage VI oocytes were injected with antibodies, enzymes, or plasmids
(Gurdon and Wickens, 1983) using a Narishige IM 300 microinjector.  All
injections were done directly into the nucleus of the oocyte.  Oocytes receiving
double injections (plasmid and/or antibody and enzyme) were first injected with
plasmid and incubated at 18oC for 12 hours followed by injections with either
antibody or enzyme.  The oocytes were then allowed to recover for 30 minutes
at 18oC before exposure to chemical stress or heat shock.
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3.6.1  Antibody and Enzyme
Prior to injection, antibodies and enzymes were diluted 1:1 in sterile
water.  A volume of 15 nl was injected into each oocyte nucleus and then
oocytes were allowed to recover for 30 minutes at 18oC prior to experimental
treatments.
3.6.2  Plasmid DNA
For overexpression experiments, pCMV-PP5 (Chinkers 1994), pCMV-
PP5flag, pET30-K97A, pET30-R101A, and pCMV-C-90 (Russel et al., 1999)
plasmids were diluted to a final concentration of 20 ng/m l in sterile water.  A
volume of 15 nl was injected directly into the nucleus of each oocyte and
incubated for 12 hours at 18oC prior to stress treatments to allow for expression.
Plasmids microinjected for CAT assays were the CMV-CAT and
Xenopus hsp70-CAT (Landsberg et el., 1995) reporter constructs.  In these
constructs, the cytomegalovirus (CMV) or Xenopus hsp70 promoters are linked
to the chloramphenicol acetyl transferase gene (CAT) and were used as
described under CAT assays.  Plasmids were diluted in sterile water to a final
concentration of 2 ng/m l and equal amounts of DNA were injected into the
nuclei of stage VI oocytes.  Following injection, oocytes were incubated at 18oC
for 12 hours to allow for proper chromatin assembly (Landsberg et al., 1995).
In some experiments, CMV-CAT and hsp70-CAT were co-injected with
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expression vectors for PP5, C-90, K97A, or R101A or with antibodies and
enzymes (as indicated in the figures).  The final injection volume was 15 nl.
Following injection, oocytes were allowed to recover for 12 hours at 18oC then
were heat shocked at 33oC for one hour or chemically stressed at 18oC for 2
hours.
3.7  Cell Transformation
DH5 a  cells were made competent using the CaCl2 method.  DH5 a  cells
were grown overnight (shaking) at 37oC in YT media (0.5% (w/v) NaCl, 1 %
(w/v) tryptone, 0.5% (w/v) yeast extract).  100 m l of these cells were taken and
added to 5 ml fresh YT media and grown (shaking) for an additional 5 hours at
37oC.  Cells were then pelleted by centrifugation at room temperature for 10
minutes at 2500 xg.  The supernatant was discarded and the pellets were
resuspended in 2.5 ml of 50 mM CaCl2 and incubated on ice for 1 hour.  Cells
were centrifuged again at room temperature for 10 minutes at 2500 xg and the
resulting pellets were resuspended in 500 m l of 50 mM CaCl2 and transferred to
a 1.5 ml microcentrifuge tube.
Transformations were subsequently carried out by adding 50-100 ng of
DNA, 9 m l of sterile water and 20 m l of TCM buffer (10 mM CaCl2, 10 mM
MgCl2, 10 mM Tris-HCl (pH 7.5)) to 100 m l of competent cells.  The resulting
mixture was incubated on ice for 1 hour, then heat shocked at 42oC for 2
minutes and allowed to recover for 15 minutes at room temperature.  300 m l of
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YT media (37oC) was added to the mixtures and incubated at 37oC for another
30 minutes.  Transformed cells were then plated onto YT/agar plates (15 g agar
for 1 L of YT media) containing the appropriate antibiotics and kept overnight
at 37oC.
Single colonies were chosen from each transformation for plasmid
isolation.  Plasmids preparations were carried out using the Wizard Prep method
available from Promega.  Isolated DNA was quantified by gel electrophoresis
using 1% agarose gels stained with 1 m g/ml ethidium bromide in 1X TAE buffer
(1 mM EDTA (pH 8.0), 40 mM Tris-acetate).  Plasmid DNA was compared
with 1 m g of l DNA digested with HindIII enzyme.
3.8  Electrophoretic Mobility Shift Assay (EMSA)
Mobility shift assays were performed using double stranded Heat Shock
Element (HSE) oligonucleotides end-labelled with 32P-dCTP (Bharadwaj et al,




To end-label HSE oligonucleotides, the following reaction mixture was
incubated at 37oC for 20 minutes: 100 ng of HSE oligonucleotides, 1 mM of
each dGTP, dATP, and dTTP, 1X Klenow buffer (New England Biolabs), 4 m l
32P-dCTP (New England Nuclear), and 1 m l of Klenow (New England Biolabs)
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to a final volume of 12 m l.  After the 20 minute incubation period, 1 mM of
dCTP was added to the mixture and incubated for another 5 minutes at 37oC.
The reaction was stopped using 12 m l of stop buffer (1% (w/v) SDS, 20 mM
EDTA (pH8.0)).  The labelled oligonucleotides were separated by
centrifugation (5 minutes at 2000 xg) using a DNA grade Sephadex (G-50)
mini-column and stored at -20oC until further use.
For gel mobility shift assays, 10 m l of stage VI oocyte protein extract
(approximately 20 m g of protein) was added to 10 m l of binding buffer (10 mM
Tris-HCl (pH 7.8), 50 mM NaCl, 1 mM EDTA (pH 8.0), 5% (v/v) glycerol)
containing 1 m g of poly dI-dC and 50 cps of radiolabelled HSE.  Reaction
mixtures were incubated at room temperature for 30 min and immediately
loaded onto a 5% non-denaturing polyacrylamide gel and electrophoresed in
TNANA buffer (6.7 mM Tris-HCl (pH 7.5), 1 mM EDTA (pH 8.0), 3.3 mM
sodium acetate (pH 5.0)) for 2 hours at 150 volts.  Gels were dried and exposed
to X-ray film (Kodak X-omat) overnight at –80oC.  Quantitation of DNA-
binding activity was performed on the resultant autoradiographs using NIH
Image Software (Version 1.6.1) and was expressed in arbitrary densitometry
units.
For supershift analysis, HSP90, PP5, p23, FKBP52, Hip, Hop, PP1, PP2A,
YY1, or PCNA antibodies were added directly to DNA-binding reactions (final
dilution of 1:20 for each) prior to the 30 min incubation at room temperature.
For super-supershift assays PP5 and FKBP52 antibodies were added to separate
reactions as above and incubated for 30 min at room temperature.  FKBP52 and
35
PP5 antibodies were then added to the PP5 and FKBP52 reactions respectively,
and incubated for another 30 min again at room temperature.
3.9  Immunoblotting
Protein extracts were separated using 10% SDS-gel electrophoresis
(Laemmli, 1970).  Proteins were transferred onto Nitrocellulose membranes
(BioRad) using the semi-dry transfer method (BioRad).  Acrylamide gels and
membranes were placed between 3 mm filter paper (BioRad) and proteins were
transferred for 30 minutes using a 20 volt.  Membranes were blocked for 2
hours while shaking at room temperature in TBST buffer (20 mM Tris-Cl (pH
7.6), 137 mM NaCl, 0.1% (v/v) Tween 20) containing 5% (w/v) blocking
powder (BioRad).  Primary antibodies PP5, PP1, PP2A, YY1, I k B, and PCNA
were diluted directly into the TBST/blocking solution containing the blot and
left shaking overnight at 4oC (a dilution of 1:5000 was used for all antibodies).
Membranes were rinsed 3 times at room temperature for 5 minutes each with
fresh TBST/blocking solution.  Blots were then incubated at room temperature
for 2 hours in fresh TBST/blocking solution containing the appropriate HRP-
conjugated secondary antibodies diluted to a final volume of 1:5000 (HRP-
conjugated goat anti-rabbit IgG and HRP-conjugated goat anti-mouse IgG,
BioRad).  Proteins were detected using chemiluminescence (Renaissance,
Dupont NEN) and autoradiography (XAR, Kodak x-ray film) after blots were
rinsed at room temperature 3 times for 5 minutes in TBST.  One stage VI oocyte
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equivalent was used for all blots unless otherwise indicated in the figure
legends.
3.10  Immunoprecipitation
Immunoprecipitations were performed using the method described by
Firestone and Winguth (1990).  Oocyte cell extracts were made in TETN250
(25 mM Tris-HCl (pH 7.5), 5 mM EDTA (pH 8.0), 250 mM NaCl, 1% (v/v)
Triton X-100) containing 10 m g/m l of both leupeptin and aprotinin.  Heat killed
Staphylococcus aureus (Staph. A) cells in formaldehyde were used as an
immunoabsorbent in order to isolate immunoprecipitated complexes (BioRad).
Prior to use in the immunoprecipitations, 1.5 ml of Staph A. cells were washed
with TETN250 and centrifuged at 10,000 xg for 30 seconds.  This tube will be
referred to as the washed Staph A. cells.  Another 1.5 ml of Staph A. cells were
pre-absorbed using oocyte extracts to decrease non-specific antibody
complexes.  This was done by washing the Staph A. cells with TETN250 and
centrifuging at 10,000 xg for 30 seconds.  The cells were then resuspended in
250 m l of whole cell oocyte extracts (made using TETN250 as the buffer) and
left at room temperature for 15 minutes.  This tube is referred to as the pre-
absorbed sample.
10 m l of washed Staph A. cells were then added to 250 m l of whole cell
oocyte extracts and the mixture was incubated at room temperature for 15
minutes.  The Staph A. cells (bound to non-specific proteins) were pelleted for 3
37
minutes at 10,000 xg and the remaining supernatant was added to fresh
microcentrifuge tube containing 100 m l of 50 mg/ml BSA in TETN250 and
either 2 m l of HSF1, PP5, YY1, or I k B antibodies.  The binding reactions were
performed overnight at 4oC.  10 m l of pre-absorbed Staph A. cells were then
added to each reaction and incubated at room temperature for 15 minutes to
bind antibody/antigen complexes.  The reactions were then layered onto 400 m l
of sucrose cushions (1.0 M sucrose/TETN250) and centrifuged for 3 minutes at
10,000 xg to separate the antibody/antigen complexes from the non-specific
bound proteins absorbed by the Staph A. cells.  The resultant pellets were then
resuspended in 1 ml of TE (10 mM Tris-Cl (pH 7.5), 5 mM EDTA (pH 8.0))
and centrifuged again for 3 minutes at 10,000 xg.  The supernatants were
discarded and the resultant pellets, containing the antibody/antigen complexes,
were resuspended in 25 m l of SDS-PAGE 1X sample buffer (New England
Biolabs) and subjected to SDS-PAGE.  Immunoprecipitated material was
analyzed by Western blotting.
3.11  CAT Assay
CAT assays using reporter constructs were performed to determine the
transcriptional activity of HSF1 (as described by Gorman et al, 1982).  CMV-
CAT was used as the control.  10 m l of protein extracts made from oocytes
injected with CMV-CAT or hsp70-CAT plasmid constructs (as described under
oocyte microinjections) was combined with 0.2 m l 100 mM Acetyl CoA and 0.5
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m l 14C-Chloramphenicol.  Reaction mixtures were incubated at 37oC for 20
minutes, extracted with 250 m l cold ethyl alcohol, and centrifuged at 14,000xg
for 4 minutes at room temperature.  The organic phase was removed and placed
in a fresh 1.5 ml microcentrifuge tube and lyophilized.  The remaining pellet
was resuspended in 10 m l ethyl acetate and spotted onto Whatman silica gel
TLC plates.  The acetylated products were separated in a TLC chamber
containing 95% chloroform and 5% methanol.  Plates were dried and exposed to
X-ray film (Kodak X-OMAT) overnight at room temperature.
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4.0  RESULTS
4.1  Subcellular localization of PP5.
PP5 is involved in regulating the activity of glucocorticoid receptors (GRs) (Chen
et al., 1996; Silverstein et al., 1997; Zuo et al., 1999; Ramsey et al., 2000), and many
of the same chaperones involved in regulating GRs appear to act as regulators of HSF1
(Zuo et al., 1998; Bharadwaj et al., 1999).  This lead to the hypothesis that PP5 may
play a role in the regulation of HSF1.  It is known that HSF1 exists as a nuclear protein
in Xenopus oocytes (Mercier et al., 1997).  In order to examine the possible
involvement of PP5 in the regulation of HSF1, the first step was to determine the
subcellular location of PP5.  Western blot analysis was performed using whole cell,
nuclear, and cytoplasmic extracts from unshocked or heat shocked stage VI oocytes
(figure 1.A).  The majority of PP5 was found in the cytoplasm (lanes 5 and 6) although
PP5 was also detected in the nucleus (lanes 3 and 4).  Interestingly, the amount of
nuclear PP5 increased slightly after heat shock indicating that translocation of PP5 may
occur.  To demonstrate the purity of the nuclear and cytoplasmic fractions, appropriate
control blots were performed: PCNA was used as a nuclear marker to determine that
nuclear fractions were not present in cytoplasmic extracts, and Ik B was used to show
that cytoplasmic proteins did not contaminate nuclear extracts.  It is important to note
that the decrease and increase observed in heat shocked whole cells oocytes and heat
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Figure 1.  Immunoblots showing the subcellular localization of PP5 in non-
shocked and heat shocked stage VI oocytes.  Oocytes were incubated at 18oC (non-
shocked=NS) or 33oC (heat shocked=HS) for 30 minutes.  Whole cell (WC), nuclear
(NUC), or cytoplasmic (CYTO) extracts were subjected to SDS-PAGE and Western
blotting.  (A)  Lanes 1-2 contain WC extracts (NS/HS), lanes 3-4 contain NUC extracts
(NS/HS), and lanes 5-6 contain CYTO extracts (NS/HS).  PP5 was detected using a
polyclonal PP5 antibody (as indicated on the left).  (B)  To determine the subcellular
localization of exogenous PP5, a PP5 Flag-tagged expression vector was microinjected
into oocytes and was allowed to express for 12 hours at 18oC before extracts were made
from NS or HS oocytes.  Flag-tagged PP5 was detected using a monoclonal FLAG
antibody.  Lanes 1-2 contain WC extracts (NS/HS), lanes 3-4 contain CYTO extracts
(NS/HS), and lanes 5-6 contain NUC extracts (NS/HS).  I k B monoclonal and PCNA
polyclonal antibodies were used in both figures 1.A and 1.B as controls to show purity
of the nuclear and cytoplasmic extracts.  All experiments were performed a minimum
of 3 times.
B.  Western Blot
A.  Western Blot
PP5
                 WC        NUC    CYTO
           NS   HS   NS   HS   NS   HS
PCNA
IκΒ




                WC        CYTO      NUC
           NS    HS    NS   HS    NS    HS
 1        2        3         4       5      6
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shocked cytoplasmic extracts (lane 2 and lane 6 respectively), were not a consistent
result and is due to experimental error.  As an additional control, the subcellular
location of exogenously expressed PP5 was tested (figure 1.B).  FLAG-tagged PP5 was
expressed by microinjection of pCMV-FLAG-PP5 and was detected in the cytoplasm
under non-shock and heat shock conditions (lanes 3 and 4).  However it was only
present in the nucleus after heat shock (lanes 5 and 6).  This further supports the finding
that PP5 undergoes nuclear translocation after heat shock.  Controls using PCNA and
Ik B confirmed the efficiency of the nuclear isolation technique after microinjection of
vectors encoding FLAG-tagged PP5 (figure 1.B).
4.2  Increasing the activity of PP5 reduces HSF1-HSE binding.
In order to determine whether PP5 is involved in the regulation of HSF1, PP5
protein levels were increased either by microinjecting oocytes with a CMV expression
vector encoding PP5, or endogenous oocyte PP5 was activated by microinjecting
pCMV-C90 plasmid encoding the C-terminus of HSP90, a known activator of PP5
(Ramsey and Chinkers, 2002) (figure 2.).  The subsequent effects on HSF1-DNA
binding was determined in comparative gel mobility shift assays.  In lanes 1 (control), 5
(+PP5), and 11 (+C-90), HSE-binding activity was undetectable under non-shock
conditions, whereas heat shock 33oC for 5, 10, 30 and 60 minutes resulted in HSF1-
HSE complex formation (lanes 2-5 (control), 7-10 (+PP5), and 12-15 (+C-90)).
However, oocytes containing elevated levels of PP5 (lanes 7-10), or activated PP5
(lanes 12-15) showed a substantial decrease in the levels of HSF1-HSE complex
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Figure 2.  Increased levels of or activation of PP5 decreases the level of HSF1-DNA
binding.  Oocytes were left uninjected (lanes 1-5) or were microinjected with pCMV-
PP5 (lanes 6-10) or pCMV-C-90 (lanes 11-15) and incubated for 12 hours at 18oC.
Oocytes were then heat shocked (HS) at 33oC for 5 mins (lanes 2, 7, 12), 10 mins (lanes
3, 8, 13), 30 mins (lanes 4, 9, 14), or 60 mins (5, 10, 15).  Control oocytes were
incubated at 18oC (non-shocked=NS; lanes 1, 6, 11).  Extracts were analyzed using gel
mobility shift assays and 32P labelled HSE.  The HSF1-HSE complex is indicated on
the left and densitometry measurements are shown below.  All experiments were
performed a minimum of three times.
Gel Shift
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formation compared to the control, uninjected oocytes (lanes 2-5).  A comparison of
HSF1-HSE complexes after 5 min of heat shock (lanes 2, 7 and 12) suggest that
elevating PP5 activity through both the activation of endogenous PP5 or the
introduction of exogenous PP5, delays or inhibits the onset of HSF1-DNA complex
formation during the induction stage of heat shock.  The levels of HSF1-DNA binding
in control samples (lanes 4 and 5) are considerably higher at later points in the heat
shock treatment compared to extracts containing elevated PP5 protein levels (lanes 9
and 10) or activated PP5 (lanes 14 and 15).  This indicates that activated or increased
levels of PP5 decrease the amount of HSF1-HSE binding not only at the onset of heat
shock but also at later phases of heat shock induction.  Both methods used to increase
PP5 activity within the cell had the same negative effect on HSF1-DNA binding.
Together these results suggest that PP5 may negatively regulate the DNA-binding
activity of HSF1 either by inhibiting HSF1 trimer formation or by promoting the rapid
disassembly of HSF1 trimers.  It is important to note that previous studies, as well as
experiments throughout this thesis, have determined that the microinjection procedure
does not affect the formation of HSF1-HSE complexes (data not shown).
4.3  Time course of PP5 effect on HSF1-HSE binding.
I next set out to determine the threshold of PP5 elevation needed to achieve a
noticeable diminishment in HSF1-HSE complex formation.  To control the increase in
PP5 protein levels in this experiment, pCMV-PP5 was microinjected into the nuclei of
stage VI oocytes and the oocytes were incubated at 18oC for 3, 6 or 12 hours.  Western
46
blot analysis was used to verify the increase in PP5 protein levels (figure 3.A).  It
should be noted here that to date, no specific phosphatase assay is available for
Xenopus oocytes to ensure that the levels of PP5 were indeed increased.  Lanes 3 and 4
show an elevation in PP5 protein levels at all time points compared to endogenous PP5
(lanes 1 and 2).  The levels of PP5 increased progressively between the 3, 6 and 12 hour
time points.   As an additional control to show that the heat shock and microinjection
procedures did not affect HSF1 protein levels, the same extracts used in lanes 1-4 were
again analyzed by Western blotting utilizing an HSF1 antibody.  No significant changes
in HSF1 protein levels were detected (lanes 5-8).
Following time to permit PP5 protein synthesis (3, 6 or 12 hours), oocytes were
either heat shocked at 33oC for 5, 10, 30 or 60 min or left unshocked at 18oC (figure
3.B).  Extracts were then subjected to electrophoretic mobility shift assay (EMSA) and
the levels of HSF1 complex formation was observed.  After allowing only 3 hours to
increase PP5 protein levels, no significant decrease was seen in the amount of HSF1-
HSE binding when compared to uninjected control samples (lanes 1-10, top panel).
However, a decrease in complex formation became more evident when the time
permitted for PP5 protein synthesis was extended to 6 hours (lanes 1-10, middle panel).
A more substantial decrease in HSF1-DNA binding activity was seen as PP5 levels
continued to increase for 12 hours (lanes 1-10, bottom panel).  It is important to note
that PP5 protein synthesis was permitted to continue for up to 18 and 24 hours and that
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Figure 3.  The effects of increased levels of PP5 on HSF1 protein levels and HSF1-
HSE DNA binding.  (A)  Immunoblots using extracts of oocytes where PP5 levels
were allowed to increase for 3, 6 or 12 hours.  Oocytes were microinjected with pCMV-
PP5 (+PP5/lanes 3, 4, 7 and 8) and incubated for 3, 6 or 12 hours at 18oC or were left
uninjected as controls (-PP5/lanes 1, 2, 5 and 6).  Oocytes were then incubated at 18oC
(non-shocked=NS) or were heat shocked (HS) at 33oC for 1 hour.  The resulting
extracts were subjected to SDS-PAGE and protein levels were detected by
immunoblotting with a PP5 or HSF1 polyclonal antibody (lanes 1-4 and lanes 5-8
respectively).  Increasing levels of PP5 and the microinjection process does not affect
HSF1 levels within the oocyte.  (B)  Gel mobility shift assays using uninjected (control)
or injected oocytes (+PP5) to determine what level of PP5 expression is required to
elicit changes in HSF1-HSE binding.  Extracts were made from uninjected oocytes
(lanes 1-5) or those injected with pCMVPP5 (lanes 6-10) and incubated for 3 6, or 12
hours at 18oC.  Oocytes were then incubated at 18oC (NS lanes 1 and 6) or heat shocked
(HS) at 33oC for 5 mins (lanes 2 and 7), 10 mins (lanes 3 and 8), 30 mins (lanes 4 and
9) or 60 mins (lanes 5 and 10).  Extracts were analyzed using EMSA and 32P
radiolabelled HSE.  The HSF1-HSE complex is indicated on the left and the
densitometry measurements are shown below.  (C)  Extracts used in figure 3.B. above
were subjected to EMSA using radiolabelled CCAAT and SP1 promoters. Increased
levels of PP5 have no effect on CCAAT and SP1 DNA binding. CCAAT and SP1
complexes are indicated on the left and densitometry measurements are shown below.
All of these experiments were performed a minimum of three times.
A.  Western Blot
 NS HS  NS HS                     NS HS  NS HS
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no further decrease in HSF1 complex formation was observed when compared to
samples synthesising PP5 for 12 hours (data not shown).  For consistency, all plasmids
were microinjected into the nuclei of oocytes and incubated at 18oC for 12 hours in all
subsequent experiments throughout this thesis.
To ensure that PP5 specifically affected the DNA binding activities of HSF1, the
same extracts used above (containing PP5 levels after 12 hours of protein synthesis),
were subjected to gel mobility shift analysis using radiolabelled oligonucleotide probes
with consensus-binding sites for other transcription factors (CCAAT and SP1) (figure
3.C).  The relative levels of either CCAAT or SP1 complex formation was not affected
by increased levels of PP5 in these experiments.  This is evident in figure 3.C. as no
change in CCAAT and SP1 binding activity was seen between lanes 1 and 10.
Together these results indicate that PP5 specifically down-regulates the inducible
DNA-binding activities of HSF1.  It is noteworthy that all experiments throughout this
thesis were repeated a minimum of three times using a minimum of 20 oocytes per
extract to ensure consistency and validity.
4.4  Inhibition of PP5 does not affect HSF1-HSE binding during the
induction of heat shock.
After observing that elevated levels of PP5 decreased the amount of heat induced
HSF1-HSE complex formation in oocytes, I next determined the effects of inhibiting
PP5 on HSF1-DNA binding activity.  Oocytes were treated for 2 hours with 100 nM
okadaic acid, a specific inhibitor of PP5 at nanomolar concentrations (Borthwick et al.,
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2001), then either heat shocked at 33oC for 5, 10, 30 or 60 minutes or left unshocked at
18oC.  The levels of HSF1-HSE complex formation were then analyzed by gel mobility
shift assay (figure 4.A).  No significant change was seen in HSF1-DNA binding
between controls (lanes 2-5) and okadaic acid treated samples (lanes 12-15).  Lanes 6-
10 contain oocytes with elevated levels of PP5 to compare activation and inhibition
treatments of PP5.  The results show that although activation of endogenous PP5
decreased the amount of HSF1-HSE binding, inhibition of endogenous PP5 had little or
no effect on DNA-binding.  DMSO was used as the vehicle control for okadaic acid
(lanes 16-20) and no significant change in HSF1 activity relative to untreated controls
was observed.
Another method used to examine the effects PP5 inhibition had on HSF1-DNA
binding was immunotargetting (figure 4.B).  An antibody specific to PP5 was
microinjected directly into the nuclei of oocytes.  After the microinjection procedure,
oocytes were allowed to recover at 18oC for 30 minutes before being subjected to heat
shock.  Control oocytes were left unshocked at 18oC.  Extracts were again analyzed
using EMSA.  Similar to results seen in figure 4.A, no increase in HSF1-HSE complex
formation was observed when comparing controls (lanes 1-5) and PP5 antibody-
injected samples (lanes 6-10).  From these results it was determined that the inhibition
or immunotargetting of PP5 had little or no effect on HSF1-HSE binding during the
induction of heat shock.  The non-specific antibody against Yin Yang 1 (YY1) was
used as an injection control (lanes 11-15) to ensure the injection procedure had no
effect on HSF1-HSE complex formation.
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Figure 4.  Chemically inhibiting endogenous PP5 has no effect on HSF1-HSE
binding during the induction phase of the heat shock response.  (A)  Uninjected,
untreated oocytes were used as controls (lanes 1-5).  PP5 protein levels were increased
as described in previous figures (lanes 6-10).  Subsets of oocytes were chemically
treated for 2 hours at 18oC with 100 nM of the PP5 inhibitor okadaic acid (lanes 11-15),
or the vehicle control DMSO (lanes 16-20).  Oocytes were then incubated at 18oC (non-
shocked=NS; lanes 1, 6, 11 and 16) or heat shocked (HS) at 33oC for 5 mins (lanes 2, 7,
12 and 17), 10 mins (lanes 3, 8, 13 and 18), 30 mins (lanes 4, 9, 14 and 19), or 60 mins
(lanes 5, 10, 15 and 20).  The resultant extracts were subjected to EMSA.  (B)  EMSA
was performed on protein extracts made from oocytes that were microinjected with
pCMV-PP5 and incubated at 18oC for 12 hours (lanes 6-10), or injected with PP5
polyclonal (lanes 11-15) or YY1 polyclonal antibodies (lanes 16-20).  Antibody
injected oocytes recovered after the injection procedure for 30 minutes at 18oC prior to
heat shock treatment.  Control oocytes were left uninjected as indicated in lanes 1-5.
Oocytes were then subjected to heat shock as described above in figure 4.A.  HFS1-
HSE complexes are indicated on the left and the densitometry measurements are shown
below.  All experiments were performed a minimum of three times.
B.  Gel Shift
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4.5  Effect of other protein phosphatases on HSF1-HSE binding activity.
Previous studies have shown that HSF1 is constitutively phosphorylated on serine
and threonine residues and becomes hyperphosphorylated in response to heat shock
(Baler et al., 1993; Sarge et al., 1993; Kline and Morimoto, 1997).  Several kinases
including glycogen synthase kinase 3b (GSK3 b ), protein kinase C (PKC), and mitogen
activated protein kinases (MAPK), have all been implicated in the regulation of HSF1
(Chu et al., 1996; Xavier et al., 1999; Holmberg et al., 1997; Kim et al., 1997).
Interestingly, although phosphorylations of HSF1 are reversible (as reviewed by
Pirkkala et al., 2001) nothing is known about how specific phosphatases might regulate
HSF1.  One study described elevated activities of PP1 and PP2A in cells
overexpressing HSP70 (Ding et al., 1998).  The authors suggested that HSP70 inhibited
HSF1 hyperphosphorylation by stimulating protein phosphatases and inhibiting protein
kinases (Ding et al., 1998), but potential roles for PP1 and PP2A in the regulation of
HSF1 were not identified.  In addition, PP2A has been found to interact with HSF2 and
PP5, although it has not yet been determined what effect if any, PP2A has on PP5
activity (Hong and Sarge, 1999; Hong et al., 2000, Lubert et al., 2001).
In light of this information, it was important to determine whether the inhibition
of HSF1-HSE complex formation in oocytes was specifically due to the phosphatase
activity of PP5 and not that of PP1 or PP2A.  To accomplish this, diluted PP1 or PP2A
enzyme (1:1) was microinjected directly into the nuclei of oocytes in order to increase
their respective activities.  Oocytes were allowed to recover after the microinjection
procedure for 30 minutes and were then incubated at 18oC as a control or heat shocked
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at 33oC for 5, 10, 30 or 60 minutes.  The resulting extracts were used for gel mobility
shift assays with radiolabelled HSE (figure 5.A).  The level of HSF1-HSE complex
formation in oocytes heat shocked for 5 minutes (lanes 2, 7, 12 and 17, figure 5.A) was
lower in samples with elevated PP5 (lane 7).  Lanes 2 (control) and 12 (PP1 injected)
showed comparable levels of HSF1-DNA binding.  Interestingly, lane 17 (PP2A
injected) also showed a decrease in HSF1-HSE complex formation in the presence of
PP2A as complex formation is approximately half that seen in control extracts (lane 2).
In the samples at 10, 30 and 60 minutes of heat shock, HSF1 activity was decreased in
cells containing elevated levels of PP5 (compare lanes 3-5 with lanes 8-10), but HSF1
activity in cells with elevated PP1 (13-15) and PP2A (18-20) levels, were the same as
controls.  These results indicate that increased levels of PP2A have only a slight effect
on HSF1-HSE binding and suggest that the decreases seen in HSF1-HSE complex
formation are specifically due to the phosphatase activity of PP5.  To ensure the levels
of microinjected PP1 and PP2A were elevated, nuclear extracts from microinjected
oocytes were subjected to Western blot analysis and the results confirm that the levels
of PP1 and PP2A were indeed increased significantly (figure 5.B).
It was also necessary to demonstrate what happens to HSF1-HSE binding when
PP2A is specifically inhibited as okadaic acid has also been shown to inhibit PP2A
activity at higher concentrations (Cohen 1989; Cohen et al., 1990).  As further control,
oocytes were treated for 2 hours with 4 m M of fostriecin, a known inhibitor of PP2A
(Walsh et al., 1997; Borthwick et al., 2001).  Oocytes were left unshocked or heat
shocked as described above and extracts were analyzed using EMSA (figure 5.C).
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Figure 5.  Other members of the protein phosphatase family do not affect the
binding activities of HSF1 during the induction of heat shock.  (A)  PP1 and PP2A
activities were increased by microinjecting purified enzyme into the nuclei of oocytes
(lanes 11-15 and lanes 16-20 respectively).  PP5 levels were increased by
microinjecting pCMV-PP5 into oocytes and allowing 12 hours for plasmid expression.
Protein extracts were made from injected or uninjected (control) oocytes as follows:
oocytes were incubated at 18oC (non-shocked=NS) or heat shocked (HS) at 33oC for 5
mins (lanes 2, 7, 12 and 17), 10 mins (lanes 3, 8, 13 and 18), 30 mins (lanes 4, 9, 14 and
19), or 60 mins (5, 10, 15 and 20).  The resultant extracts were subjected to EMSA.  (B)
Western blots of nuclear oocyte extracts confirming PP1 and PP2A elevated protein
levels.  (C)  Gel mobility shift assay using protein extracts from uninjected oocytes
(control lanes 1-5), oocytes that were injected with pCMV-PP5 and incubated for 12
hours (+PP5 lanes 6-10), or oocytes that were treated with 4 m M of the PP2A specific
phosphatase inhibitor fostriecin (+fostriecin lanes 11-15).  Oocytes were then incubated
at 18oC (NS) or heat shocked (HS) as above in figure 5.A.  HSF1-HSE specific binding
is indicated on the left and the densitometry measurements are shown below.  All
experiments were performed a minimum of three times.
A.  Gel Shift
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Oocytes containing elevated levels of PP5 (lanes 6-10) showed a significant decrease in
HSF1-HSE complex formation when compared to control (lanes 1-5) and fostriecin
treated oocytes (lanes 12-15).  No change in HSF1-DNA binding was observed
between controls (lanes 1-5) and fostriecin treated oocytes (lanes 11-15).  This
demonstrates that inhibition of PP2A had no effect on HSF1-HSE binding as observed
in figure 5.A (lanes 16-20).  These results illustrate that when endogenous PP2A is
inhibited, the level of heat-induced HSF1-HSE complexes remains unchanged (figure
5.C).  Therefore, the inhibitory effect on HSF1-DNA binding observed in previous
experiments was likely due to the specific phosphatase activity of PP5.
4.6  PP5 decreases the amount of HSF1-HSE binding in response to
stresses other than heat shock.
The previous experiments establish that elevated levels of activated PP5 suppress
the formation of HSF1-HSE complexes under heat shock conditions.  Next I wanted to
determine if this phenomenon was restricted to heat shock, or if similar inhibitory
effects could be observed using stress treatments other than heat shock.  Studies using
tissues culture cells and Xenopus oocytes have shown that HSF1-HSE binding can be
activated by sodium salicylate, sodium arsenite, cadmium chloride, or ethanol (Jurivich
et al., 1992, 1995; Bharadwaj et al., 1999).  Control oocytes and oocytes with elevated
PP5 levels were chemically treated for 2 hours with 70 mM sodium salicylate, 5 mM
sodium arsenite, 20 mM cadmium chloride, or 10% ethanol.  The resulting extracts
were subjected to EMSA using radiolabelled HSE (figure 6).  Lanes 2 and 4 compare
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Figure 6.  Increased levels of PP5 decrease HSF1-DNA binding during stresses
other than heat shock.  Protein extracts were prepared using oocytes uninjected (lanes
1-2, 5, 7, 9 and 11) or injected with pCMV-PP5 and incubated for 12 hours at 18oC
(lanes 3-4, 6, 8, 10 and 12).  Oocytes were then treated at control (non-shocked=NS)
temperature (18oC) (lanes 1 and 3), heat shocked (HS) at 33oC for 1 hour (lanes 2 and
4), or chemically stressed for two hours at 18oC by treatment with 70 mM salicylate, 5
mM arsenite, 50 mM cadmium, or 10% ethanol (v/v) (lanes 5-6, 7-8, 9-10, 11-12
respectively).  Extracts were subjected to EMSA using radiolabelled HSE.  The HSF1-
HSE complex is indicated on the left and densitometry measurements shown below.
All experiments were performed a minimum of three times.
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HSF1-HSE binding in heat shocked control (uninjected) and PP5-elevated samples.
Approximately a two-fold reduction in HSF1-HSE complex formation was observed in
PP5-expressing cells.  Similarly, a two-fold reduction in HSF1-DNA binding was seen
in salicylate (compare lanes 5-6), arsenite (lanes 7-8), cadmium (lanes 9-10), and
ethanol (lanes 11-12) treated oocytes.  These results show a consistent decrease in
HSF1-HSE binding in chemically stressed oocytes brought about by elevated levels of
PP5.  It therefore appears that PP5 plays a similar negative-regulatory role in various
stress regimes.
4.7  PP5 activation or upregulation increases the rate of HSF1-HSE
deactivation.
I have demonstrated that by increasing the levels of PP5, either through activating
endogenous PP5 or by plasmid-directed overexpression, HSF1-HSE binding is
repressed during the induction phase of the heat shock response (figures 2 and 3).  The
recovery profile of HSF1-DNA binding has been investigated in Xenopus oocytes and it
is known that HSF1 attenuates rapidly after the removal of heat shock (Bharadwaj et
al., 1999).  Knowing that PP5 acts to decrease HSF1-HSE binding during induction of
heat shock, I wanted to determine if increased levels or activated PP5 would decrease
HSF1-DNA binding or accelerate the attenuation phase of heat shock (figure 7).
Oocytes containing activated PP5 or those injected with expression vectors encoding
PP5 were heat shocked for 1 hour at 33oC and allowed to recover at 18o for 0, 5, 15, 30
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Figure 7.  Elevated PP5 protein levels decrease HSF1-DNA-binding during the
attenuation phase of the heat shock response.  Oocytes were left uninjected (control,
lanes 1-6) or PP5 and C-90 levels were increased by injecting stage VI oocytes with
pCMV-PP5 or pCMV-C-90 (lanes 7-12 and lanes 13-18 respectively).  After allowing
12 hours for plasmid expression, oocytes were incubated  at 18oC (non-shocked=NS;
lanes 1, 7 and 13) or were heat shocked (HS) at 33oC and allowed to recover at 18oC for
0 mins (lanes 2, 8 and 14), 5 mins (lanes 3, 9 and 15), 15 mins (lanes 4, 10 and 16), 30
mins (lanes 5, 11 and 17) or 60 mins (lanes 6, 12 and 18).  The resultant protein extracts
were subjected to gel mobility shift assay.  HSF1-HSE complexes are indicated on the
left and the densitometry measurements are shown below.  All experiments were
performed a minimum of three times.
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or 60 minutes.  Control oocytes were incubated at 18oC and extracts were subjected to
EMSA.  In control, uninjected oocytes (lanes 1-6), a high level of HSF1-HSE complex
formation was observed immediately after heat shock, and complexes disappeared by
15-30 minutes of recovery.  In contrast, there was less HSF1-HSE complex formation
immediately after heat shock in PP5-expressing (lanes 7-12) or PP5-activated cells
(lanes 13-18), and HSF1-HSE complexes disappeared more rapidly between 5 and 15
minutes, compared to 15-30 minutes in controls (compare lanes 4, 10 and 16).  This
suggests that PP5 may be involved in the negative regulation of HSF1-DNA binding
activities during the attenuation phase of heat shock either by inhibiting HSF1 trimer
formation or by accelerating the disassembly of HSF1 trimers.
4.8  The inhibition of PP5 prolongs HSF1-HSE binding.
I have shown that activated or elevated levels of PP5 decreased HSF1-HSE
complex formation during heat shock recovery (figure 7).  These observations
suggested that PP5 functions to repress HSF1 and the stress response.  I next
hypothesized that the inhibition of PP5 would either activate HSF1 trimer formation
(and hence HSF1-HSE complex formation) or inhibit the dissociation of complexes,
resulting in prolonged retention of HSF1-HSE complexes during recovery from heat
shock (figure 8).  In order to determine the effect of PP5 inhibition on recovery from
heat shock, oocytes were treated with 100 nM of the PP5 inhibitor okadaic acid and left
at 18oC for 2 hours.  Treated and untreated control oocytes were either left unshocked
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Figure 8.  Inhibiting endogenous PP5 prolongs DNA-binding in the attenuation
phase of the heat shock response.  (A)  Gel mobility shift assays were performed with
protein extracts made from oocytes that were untreated (control-lanes 1-6), or treated
for two hours at 18oC with the 100 nM of the PP5 inhibitor okadaic acid (lanes 7-12) or
the vehicle control DMSO (lanes 13-18).  Oocytes were left non-shocked (NS) at 18oC
(lanes 1, 7 and 13) or were heat shocked (HS) at 33oC and allowed to recover at 18oC
for 0 mins (lanes 2, 8 and 14), 5 mins (lanes 3, 9 and 15), 15 mins (lanes 4, 10 and 16),
30 mins (lanes 5, 11 and 17), or 60 mins (lanes 6, 12 and 18).  (B)  A similar recovery
experiment was performed using oocytes that were uninjected (lanes 1-5) or injected
with PP5 or YY1 polyclonal antibodies (lanes 5-10 and lanes 11-15 respectively).
Oocytes were left non-shocked (NS) at 18oC (lanes 1, 6 and 11) or were heat shocked
(HS) at 33oC and allowed to recover at 18oC for 0 mins (lanes 2, 7 and 12), 5 mins
(lanes 3, 8 and 13), 15 mins (lanes 4, 9 and 14), or 30 mins (lanes 5, 10 and 15).  The
HSF1-HSE specific complexes are indicated at the left and the densitometry
measurements are shown below.  All experiments were performed a minimum of three
times.
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at 18oC or heat shocked at 33oC for 1 hour.  Heat shocked oocytes were then allowed to
recover at 18oC for 0, 5, 15, 30 or 60 minutes.  The samples were analyzed by gel
mobility shift assay to test for HSF1-HSE complexes (figure 8.A).  In controls (lanes 2-
4) there was a rapid decline in HSF1-HSE complex formation after removal of heat
shock up until HSF1-DNA binding was no longer detectable in oocytes allowed to
recover for 30 or 60 minutes after heat shock (lanes 5 and 6).  However, oocytes treated
with okadaic acid showed an extension of HSF1-HSE binding as binding was still
detected after 60 minutes recovery (lanes 14-18).  The differences detected in HSF1-
HSE binding were particularly noticeable at the 15 and 30 minute time points.  After 15
minutes, control samples (lane 4) showed approximately a 4-fold decline in HSF1-HSE
complex formation compared to no significant decline in complex formation in okadaic
acid treated samples (lane 16).  After 30 minutes of recovery there were no detectable
HSF1-HSE complexes in control samples (lane 5) whereas in comparison, okadaic acid
treated oocytes (lane 17) retained a significant level of binding.  This indicates that the
dissociation of HSF1-HSE complexes is greatly prolonged when PP5 is inhibited and
suggests that PP5 may normally act to promote the dissociation of HSF1 trimers (figure
8.A).  HSF1-HSE binding was not observed in any of the non-shocked samples (lanes 1
and 13), therefore it may be unlikely that PP5 alone suppresses HSF1 trimer formation
as inhibition of PP5 might then have resulted in the formation of HSF1 trimers.
Oocytes treated with DMSO (lanes 7-12), the vehicle for okadaic acid, had similar
amounts of HSF1-HSE complex formation when compared to control oocytes (lanes 1-
6).
69
In addition to okadaic acid, immunotargetting was used to inhibit PP5.  Polyclonal
PP5 antibodies were microinjected directly into oocyte nuclei and samples were treated
as above.  The results observed were similar to the effects seen on HSF1-DNA binding
when okadaic acid was used to inhibit PP5 activity (figure 8.B).  HSF1-HSE binding
was prolonged in PP5 inhibited oocytes (lanes 7-10) when compared to control,
uninjected oocytes (lanes 2-5).  More specifically, HSF1-HSE binding was present in
both control and PP5-inhibited oocytes 15 minutes after removal from heat shock,
however the binding in control oocytes (lane 4) was approximately half of that
observed in PP5-inhibited oocytes (lane 9).  DNA binding was still detectable 30
minutes after PP5-inhibited oocytes were removed from heat shock (lane 10) but was
not detected in controls (lane 5).  These results support the suggestion that PP5
functions to promote the dissociation of HSF1 trimers.  Interestingly, there was no
induction of HSF1-HSE binding in non-shocked oocytes treated with okadaic acid
(figure 8.A lane 13), however, inhibition of PP5 by antibody injection showed slight,
but reproducible DNA binding in non-shocked oocytes (figure 8.B lane 6).  This may
suggest that PP5 acts to suppress trimer formation as HSF1-HSE binding was not
detected in control, non-shocked oocytes (lane 1).  However, this effect appeared to be
restricted to immunotargetting experiments only.  A non-specific antibody against Yin
Yang 1 (YY1) was used as an injection control (lanes 11-15) indicating that the
presence of antibody did not result in prolonged attenuation or induction of DNA
binding under non-shock conditions.  Together, these results further support the
previous conclusions that PP5 acts as a negative regulator of HSF1 and suggests that
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rather then repressing trimer formation, PP5 may promote more rapid trimer
disassembly.
4.9  Other protein phosphatase family members do not affect HSF1-
DNA binding during the attenuation phase of heat shock.
In order to determine if the rapid recovery of HSF1-HSE binding during the
attenuation phase of heat shock was specifically attributable to the activities of PP5, the
activities of two other members of the protein phosphatase family were increased.  PP1
and PP2A enzyme was microinjected directly into the nuclei of oocytes as was done in
Figure 5.A.  Oocytes were incubated at control temperatures (18oC) or were heat
shocked for 1 hour at 33oC and allowed to recover at 18o for 0, 5, 15, 30 or 60 minutes.
The resultant extracts were subjected to EMSA (figure 9.A).  No difference in HSF1-
HSE complex formation was observed in oocytes microinjected with PP1 (lanes 7-12)
or PP2A (lanes 13-18) when compared to uninjected control oocytes (lanes 1-6).  These
results demonstrate that increased levels of PP1 and PP2A have no effect on HSF1-
HSE binding and suggest that it is the specific phosphatase activity of PP5 and not PP1
or PP2A that negatively modulates HSF1-HSE complex formation during the
attenuation phase of heat shock.
Endogenous PP2A was also inhibited as in figure 5 by treating uninjected oocytes
for two hours with 4 m m fostriecin at 18oC.  Extracts were again subjected to EMSA
(figure 9.B).  Oocytes containing elevated levels of PP5 resulted in decreased HSF1-
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Figure 9.  Other members of the protein phosphatase family do not affect the
binding activities of HSF1 during the attenuation phase of the heat shock
response.  (A)  The levels of PP1 and PP2A were elevated by nuclear injection of
purified enzyme (lanes 7-12 and lanes 13-18 respectively).  Uninjected oocytes were
used as a control (lanes 1-6).  After allowing 30 minutes for the oocytes to recover after
the injection procedure (at 18oC), oocytes were incubated at 18oC (non-shocked=NS) or
were heat shocked (HS) at 33oC and allowed to recover at 18oC for 0 mins (lanes 2, 8
and 14), 5 mins (lanes 3, 9 and 15), 15 mins (lanes 4, 10 and 16), 30 mins (lanes 5, 11
and 17) or 60 mins (lanes 6, 12 and 18).  The resultant protein extracts were subjected
to EMSA.  (B)  Gel mobility shift assay with protein extracts made from uninjected
oocytes (lanes 1-6), oocytes incubated with injected pCMV-PP5 for 12 hours at 18oC
(lanes 7-12), or oocytes treated with 4 m M of the PP2A phosphatase inhibitor fostriecin
(lanes 13-18).  Each treated subset of oocytes were then subjected to control (NS)
temperatures (18oC) or heat shocked (HS) at 33oC as described above in figure 9.A.
The HSF1-HSE complex is indicated on the left and the densitometry measurements
are shown below.  All experiments were repeated a minimum of three times.
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HSE complex formation immediately after heat shock (lane 8) compared to control
(lane 2) and fostriecin treated oocytes (lane 14), and less DNA binding was detected
after 5 and 15 minutes of recovery (compare lanes 3, 4 and 9, 10 and 15, 16) compared
to controls (lanes 2 and 3) and fostriecin treated oocytes.  However, a decrease in the
amount of HSF1-HSE complex formation was seen when comparing control and
fostriecin treated samples suggesting that inhibition of PP2A may effect HSF1-DNA
binding (compare lanes 1-6 to lanes 14-18).  This affect was minimal and it is most
likely that the decrease in HSF1-HSE complex formation in these experiments is due to
the phosphatase activity of PP5.
4.10  PP5 and HSF1-dependent transcription.
The DNA binding and transcriptional activities of HSF1 are known to be
separately regulated (Hensold et al., 1990; Jurivich et al., 1992; Bharadwaj et al.,
1999).  Using gel mobility shift analysis, I have found that PP5 negatively regulates
HSF1-DNA binding at the level of trimer formation/disassembly.  To examine whether
PP5 plays a role in controlling the transcriptional activity of HSF1, a series of
transcription assays using CAT reporter constructs were performed (figure 10).  Hsp70-
CAT, containing the HSF1-dependent promoter of hsp70, was microinjected into stage
VI oocytes.  In order to control for potential effects of injected plasmids and enzymes
or chemical treatments on general transcription, oocytes were also injected with the
CMV-CAT construct containing a non-stress inducible promoter.  To determine what
effect PP5 activities had on HSF1-regulated transcription, reporter constructs were co-
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Figure 10.  Analysis of HSF1 transcriptional activity using hsp70-CAT reporter
constructs.  (A)  Oocytes were microinjected with pCMV-PP5 and/or hsp70-CAT or
CMV-CAT and allowed to incorporate plasmid DNA as described by Landsberg et al.,
(1995).  CAT assays were performed using extracts from oocytes that were
microinjected with the reporter plasmids hsp70-CAT or CMV-CAT and pCMV-PP5
(panel 1), PP1 (panel 2) or PP2A (panel 3) enzyme, or chemically treated for 2 hours at
18oC with 4 m M fostriecin (panel 4), 100 nM okadaic acid (panel 5), or (v/v)% of the
vehicle control DMSO (panel 6).  Oocytes were then incubated at 18oC for 12 hours
and treated by non-shock (NS 18oC) or heat shock (HS) at 33oC for one hour.  Thin-
layer chromatography was used to separate the acetylated (Ac) and non-acetylated form
of chloramphenicol (Cm).  (B)  CAT assays were performed using extracts from
oocytes that were microinjected with the reporter plasmids hsp70-CAT or CMV-CAT.
pCMV-PP5 was also injected into oocytes used in lanes 3-4, 6, 8 and 10 and incubated
at 18oC for 12 hours .  Oocytes were then incubated at the non-shock temperature of
18oC, heat shocked (HS) at 33oC for one hour, or chemically treated at 18oC for two
hours with 70 mM salicylate (lanes 5 and 6), 50 mM cadmium (lanes 7 and 8), or 10%
ethanol (lanes 9 and 10).  Extracts were then subjected to CAT.  The acetylated and
non-acetylated forms of chloramphenicol are indicated on the right.  All experiments
were repeated a minimum of three times.
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injected with expression vectors for PP5 or oocytes were treated with okadaic acid (PP5
inhibitor), DMSO (vehicle control), or fostriecin (PP2A inhibitor).  PP1 and PP2A
enzymes were also microinjected directly into the nuclei of oocytes to see what effect
phosphatases other than PP5 had on HSF1 transactivation (figure 10.A).  To minimize
sample variability, all treatments in this experiment (10.A and 10.B) were performed
using the same set of oocytes.  The results in panel 1 illustrate that increased levels of
PP5 significantly decrease HSF1-dependent transcription of the hsp70 promoter.
Interestingly, PP5 completely inhibited heat shock-induced transcription, even though
under the same conditions, residual HSF1-HSE complex formation was still detected in
DNA binding assays (figures 2, 3 and 8).  This suggests that PP5 acts to negatively
regulate HSF1-DNA binding as well as HSF1 transcriptional activation.  Inhibition of
PP5 with okadaic acid had no effect on HSF1 transactivation (panel 5), consistent with
the effects on DNA binding in okadaic acid treated oocytes (figures 4 and 8).  Although
PP5 inhibition delayed the attenuation of HSF1-DNA binding (figure 8), it did not
affect hsp70 promoter activity.  It is also important to note that C-90 or PP5 antibody
could not be used to activate or inhibit PP5 in this assay as both were repeatedly found
to interfere with general CMV-CAT expression (data not shown).
The results shown in Panel 2 illustrate that increased levels of PP1 had no effect
on HSF1-mediated transcription of the hsp70 promoter in heat shocked oocytes.  Again
this agrees with previous experiments demonstrating that PP1 had no effect on HSF1-
HSE binding (figures 5 and 9).  Interestingly, panel 3 shows that increased levels of
PP2A resulted in decreased hsp70 promoter activity.  As expected, the hsp70 promoter
activity increased when PP2A was inhibited using fostriecin (panel 4).  Previous
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experiments indicated that these treatments had no effect on HSF1-HSE binding
suggesting that PP2A may play a role in regulating HSF1 at the level of transcription
but not at the level of DNA binding.
Next I wanted to determine if PP5 could suppress the transcriptional activity of
HSF1 in response to stresses other than heat shock.  Oocytes were microinjected with
expression vectors encoding PP5 and reporter constructs then treated with heat shock,
sodium salicylate, cadmium chloride, or ethanol.  The results of the CAT assays
illustrate that in addition to the suppression of HSF1-DNA binding (figure 6), elevated
levels of PP5 also decreased the transcriptional activity of HSF1 (figure 10.B).  HSF1-
mediated transcription was reduced in response to heat shock (lanes 3, 4) and cadmium
(lanes 7, 8) suggesting that PP5 acts to regulate the transcriptional activities of HSF1 in
stress conditions other than heat shock.  It is important to note that in Xenopus oocytes,
not all stresses capable of activating HSF1-HSE binding activate HSF1 dependent
transcription (Bharadwaj et al., 1999).  Cadmium was the only stress used in this thesis
other than heat shock that has been shown to activate HSF1 transcriptional activity
(Bharadwaj et al., 1999).  Consistent with these previous observations, salicylate (lanes
5, 6) and ethanol (lanes 9, 10) treatments did not induce hsp70 promoter activity.
Parallel control experiments were performed using CMV-CAT injected oocytes to
demonstrate that the treatments used in these experiments had no effect on general
transcription (figure 10.B bottom).
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4.11  PP5 interacts with HSF1 complexes.
After observing that PP5 was present in oocyte nuclei and the apparent negative-
regulatory role of PP5 on HSF1 DNA-binding and transcriptional activities, I next
wanted to explore the possibility of a physical interaction between PP5 and the HSF1
heterocomplex.  In vitro and in vivo studies have shown that the HSF1 complex
interacts with the proteins HSP40, Hip (HSP70 interacting protein), Hop (HSP90 and
HSP70 organizing protein), HSP90, HSP70, p23, and the immunophilins (FKBP51,
FKBP52, or cyp40) (as reviewed by Morimoto, 1998; Bharadwaj et al., 1999; Guo et
al., 2001).  As well, Guo et al., (2001) have recently shown evidence, using co-
immunoprecipitations, that PP5 may interact with the HSF1 heterocomplex.  In order to
determine whether PP5 interacts with the HSF1 complex in Xenopus oocytes, a gel
mobility supershift analysis was performed using PP5 antibodies to test for effects on
the HSF1-HSE complex (figure 11.A).  Previous studies have shown that proteins
found within the HSF1 complex can be identified when specific antibodies are
incubated with oocyte extracts in DNA-binding reactions with radiolabelled HSE
(Bharadwaj et al., 1999).  Antibodies that recognize HSF1 heterocomplex constituents
result in a supershift of the HSF1-HSE complex (Bharadwaj et al., 1999).  Figure 11.A
shows the results of a gel mobility supershift experiment using non-shocked and heat
shocked oocyte extracts.  HSP90, p23, and FKBP52 antibodies were used as positive
controls for supershifts, and no antibody, or antibodies of proteins that are not in these
complexes (Hop, YY1, and PCNA) were used as negative controls (lane 2).  The DNA
binding reactions with no antibodies served as a control to show the normal migration
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Figure 11.  Gel mobility supershift assay and co-immunoprecipitation illustrating
interactions between PP5 and HSF1.  (A) No antibody (lanes 1 and 2) or antibodies
against HSP90, (lanes 3 and 4), PP5 (lanes 5 and 6), p23 (lanes 7 and 8), FKBP52
(lanes 9 and 10), PP1 (lanes 11 and 12), PP2A (lanes 13 and 14), Hop (lanes 15 and
16), YY1 (lanes 17 and 18), and PCNA (lanes 19 and 20) were incubated with
radiolabelled HSE at room temperature for 30 minutes with non-shocked (NS-18oC) or
heat shocked (HS-33oC for 1 hour) oocyte extracts.  Incubated samples were
electrophoresed on an acrylamide gel and HSF1-HSE complexes were detected
(labelled HSF1).  Antibodies that bind HSF1 show a supershift in the HSF1-HSE
complex.  (B) Immunoprecipitation using non-shocked (NS-18oC lanes 1, 4 and 7) and
heat shocked (HS-33oC for 1 hour lanes 2, 5 and 8) oocyte extracts.  Co-
immunoprecipitations were performed with an HSF1 polyclonal
antibody/immunoblotted with PP5 polyclonal antibody (top lanes 1-3) and PP5
antibody/immunoblotted with an HSF1 antibody (bottom lanes 1-3) to illustrate that
PP5 interacts with HSF1.  I k B and YY1 antibodies were used as negative controls (top
and bottom lanes 4-6 and 7-9 respectively).  Diluted HSF1, PP5, Ik B, and YY1
antibodies were run as an additional control (lanes 3, 6 and 9).  All experiments were
performed a minimum of three times.
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of HSF1-HSE complexes in heat shocked oocytes.  Lane 4 (HSP90), lane 8 (p23), and
lane 10 (FKBP52) act as positive controls to show the retarded or supershifted
migration pattern of the HSF1-HSE complex when antibody against a member of the
heterocomplex is present in the DNA binding reaction.  Similar migration to that found
in lane 2, in which no apparent supershifting of the HSF1-HSE complex was observed,
was seen with addition of antibodies to PP1 (lane 12), PP2A (lane 14), HOP (lane 16),
YY1 (lane 18), and PCNA (lane 20).  Therefore PP1, PP2A, HOP, and YY1 do not
appear to interact with the HSF1 heterocomplex under the conditions used.  Addition of
PP5 antibody (lane 6) resulted in a supershifted migration pattern similar to that of the
positive controls, HSP90 (lane 4), p23 (8), and FKBP52 (10).  This indicates that PP5
may interact with the HSF1 heterocomplex.  PP1 and PP2A antibodies did not
supershift or diminish the HSF1-HSE complex (lanes 12 and 14).
Next I determined if PP5 could be co-immunoprecipitated with HSF1.  HSF1 was
immunoprecipitated from non-shocked and heat shocked oocytes using an HSF1
polyclonal antibody (figure 11.B (top) lanes 1 and 2) and the immunoprecipitated
material was examined for the presence of PP5 by Western blotting.  The results
showed that PP5 was present in the HSF1-immunoprecipitated material under both non-
shock and heat shock conditions.  The reciprocal immunoprecipitation and Western blot
was also performed using a PP5 polyclonal antibody (figure 11.B (bottom) lanes 1 and
2) and showed that HSF1 was present in the PP5-immunoprecipitated material, again
under both non-shock and heat shock conditions.  In order to demonstrate that the IgG
portion of the antibody was not detected as bands on the Western blots, diluted HSF1
and PP5 antibody were added to an oocyte extract and subjected to Western blotting
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(lane 3 top and bottom).  The results indicate that the IgG portion of the antibody does
not interfere with the immunoprecipitation results as no banding was detected on
Western blots at the level of HSF1 or PP5.  As an additional control,
immunoprecipitations were also performed as above using Ik B and YY1 antibodies.
Neither PP5 or HSF1 were found in the control immunoprecipitations using these
antibodies (lanes 4-6 and 7-9 top and bottom).  These results along with the previous
supershift (figure 11.A) confirm that PP5 interacts with and is a component of the
HSF1-HSP90 heterocomplex.  PP5 was identified with HSF1 in both non-shocked and
heat shocked extracts indicating that PP5 interacts with both inactive HSF1 monomers
and DNA binding HSF1 trimers under control and heat shock conditions respectively.
4.12  PP5 affects HSF1-HSE binding and HSF1 transactivation
independently of HSP90.
It is known that PP5 contains a TPR domain that recognizes and binds HSP90,
and it is through this interaction that PP5 associates with and regulates the activities of
GRs (Chen et al., 1996; Silverstein et al., 1997).  Since PP5 supershifted the HSF1-
HSE complex (figure 11.A) and co-immunoprecipitated with HSF1 (figure 11.B), I
next investigated whether PP5 exerts its effects on HSF1-DNA binding independently
of being bound to HSP90.  This was tested using full-length PP5 mutants (K97A and
R101A) containing single alanine substitutions within the TPR binding domain.  These
PP5 mutants are known to retain full phosphatase activity and immunoprecipitation
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experiments using COS-7 cells have shown that each mutant is unable to bind HSP90
(Russell et al., 1999).  Oocytes were microinjected with constructs encoding either
wild-type PP5 or PP5 mutants K97A or R101A, and were incubated at the control
temperature of 18oC or were heat shocked at 33oC for 5, 10, 30 or 60.  The extracts
were then analyzed using EMSA to determine if non-HSP90 binding mutants could
affect the activity of HSF1 (figure 12.A).  A similar reduction in the amount of HSF1-
HSE complex formation was observed after expression of PP5 (lanes 6-10), K97A
(lanes 11-15), and R101A (lanes 16-20) at each time point relative to the level of
HSF1-HSE complex formation induced by heat shock in uninjected oocytes (lanes 1-5).
This suggests that PP5 decreases HSF1-HSE binding during the induction stage of heat
shock regardless of its capacity to bind HSP90.  However, the decrease in HSF1-DNA
binding was more pronounced in oocytes expressing wild-type PP5 in comparison to
those expressing mutant PP5.
To confirm that the increases in protein levels of PP5 and the K97A and R101A
mutants were relatively equal, and that their levels did not change under heat shock
conditions, a Western blot was performed using extracts from figure 12.A.   The results
show that the elevated protein levels of wild-type and mutant PP5 are similar,
approximately 10-fold higher than that of endogenous PP5, and do not change under
heat shock conditions.
Oocytes were also injected as above and tested in recovery experiments
in which a 1 hour 33oC heat shock was followed by recovery for 0, 5, 15, 30
or 60 minutes at 18oC.  The extracts were again analyzed using EMSA to
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Figure 12.  PP5 interacts with and elicits its effect on HSF1-HSE complex
independently of HSP90.  (A)  Wild-type PP5 and PP5 mutants (K97A and R101A)
that are unable to bind HSP90 as a result of mutations to the TPR domain were injected
into oocytes that were incubated for 12 hours at 18oC.  Uninjected (control lanes 1-5) or
injected with pCMV-PP5 (lanes 6-10), pET30-K97A (lanes 11-15), or pET-R101A
(lanes 16-20).  Uninjected and injected oocytes were incubated at 18oC (non-
shocked=NS lanes 1,6,11, and 16) or were heat shocked (HS) at 33oC for 5 mins (lanes
2, 7, 12 and 17), 10 mins (lanes 3, 8, 13 and 18), 30 mins (4, 9, 14 and 19), or 60 mins
(lanes 5, 10, 15 and 20).  (B)  Western blot to ensure that the increased levels of wild-
type and mutant PP5 are comparable in the above experiments.  Non-shocked (NS) and
heat shocked (HS at 33oC for 60 minutes) protein extracts used in figure 12.A. above
were used and immunoblotted with a polyclonal PP5 antibody.  (C)  Oocytes were
injected as in figure 12.A. and treated at control (NS-18oC lanes 1, 7, 13 and 19)
temperatures or heat shocked at 33oC for 1 hour and allowed to recover at 18oC for 0
mins (lanes 2, 8, 14 and 20), 5 mins (3, 9, 15 and 21), 15 mins (4, 10, 16 and 22), 30
mins (5, 11, 17 and 23), and 60 mins (6, 12, 18 and 24).  Extracts were subjected
EMSA using radiolabelled HSE.  The HSF1-HSE specific complex is indicated on the
left and the densitometry is shown below.  All experiments were performed a minimum
of three times.
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compare the effects on HSF1-HSE complex formation (figure 12.C).  The level of
HSF1-HSE complex formation was similar in oocytes injected with constructs
encoding PP5 (lanes 7-12), K97A (lanes 13-17), and R101A (lanes 19-24), and each
time point was less than that of control, uninjected oocytes (lanes 1-6).  Again, slightly
more HSF1-HSP90 complexes were formed in oocytes containing mutant PP5 when
compared to those containing wild-type PP5. The results of this experiment illustrate
that PP5 and the non-HSP90 binding mutants, exert the same inhibitory effects on
HSF1-HSE binding in the oocyte.
4.13  PP5 mutants and HSF1 transcriptional activation.
Transcription assays were performed as described in figure 10, to determine if the
PP5 mutants (K97A and R101A) also affected heat-induced HSF1 transactivation of the
hsp70 promoter (figure 13).  Hsp70-CAT or control CMV-CAT reporter constructs
were co-injected with expression vectors for wild-type and mutant PP5 (K97A and
R101A).  The results presented in panel 1 indicate that elevated levels of PP5
completely inhibited the promoter activity of hsp70.  Panels 2 and 3 show transcription
assays for oocytes with increased levels of the PP5 mutants (K97A and R101A) and
demonstrate a similar inhibition of HSF1-mediated transcription when compared to that
observed in oocytes containing wild-type PP5.  The mutants repressed HSF1
transcriptional activation, to the same extent as that of wild-type PP5.  This implies that
the phosphatase activity of PP5 could regulate HSF1-DNA binding and HSF1
transactivation independently of being bound to HSP90.
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Figure 13.  Analysis of HSF1 transcriptional activity using hsp70-CAT reporter
constructs and PP5 mutants.  Oocytes were microinjected with pCMV-PP5, pET30-
K97A, or pET30-R101A and/or hsp70-CAT or CMV-CAT and incubated for 12 hours
at 18oC.  Oocytes were then incubated at non-shock temperature (NS 18oC) or heat
shocked (HS) at 33oC for one hour.  Extracts were then subjected to CAT assay.  Thin-
layer chromatography was used to separate the acetylated (Ac) and non-acetylated form
of chloramphenicol (Cm) (as indicated on the right).  All experiments were performed a
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Figure 4.14  PP5 is present in HSF1 heterocomplexes containing an immunophilin.
Previous studies involving glucocorticoid receptors and HSF1 illustrate that only
one immunophilin interacts with the HSF1 heterocomplex at any given time (Ratajczak
and Carrello, 1996; Chen et al., 1996; Silverstein et al., 1997; Owens-Grillo et al.,
1998; Bharadwaj et al., 1999; Chinkers, 2001).  Furthermore, additional studies have
demonstrated that PP5 cannot bind GRs if an immunophilin is present, as they both
bind HSP90 at the same location (Chen et al., 1996; Silverstein et al., 1997).  Using co-
immunoprecipitations and gel mobility supershifts, I have shown evidence that PP5 is a
component of HSF1 heterocomplexes (figure 11).  Figures 12 and 13 illustrated that
PP5 may bind the HSF1 heterocomplex and affect HSF1 activity independently of
binding to HSP90 suggesting that the interactions between HSF1 and PP5 are different
than those between GRs and PP5.  In order to investigate this hypothesis further, gel
mobility supershift assays were performed to determine if PP5 and the immunophilin
FKBP52 are present within the same HSF1 heterocomplexes, or if interactions between
PP5 and FKBP52 are mutually exclusive (figure 14).  Similar to the supershift assays
performed in figure 11.A, non-shock (18oC) and heat shocked (33oC for 1 hour) oocyte
extracts were used to detect migration changes in HSF1-HSE complexes.  The
migration of the HSF1-HSE complex in uninjected heat shocked extracts is seen in lane
2.  Binding reactions shown in lanes 4 and 8 contain PP5 or FKBP52 antibodies.  As
also seen in figure 11, these antibodies supershifted the HSF1-HSE complex when
compared to extracts without antibody (lane 2), suggesting that these proteins are
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Figure 14.  Super-supershifts showing the presence of both PP5 and FKBP52 in
the HSF1-heterocomplex.  Oocytes were incubated with radiolabelled HSE at room
temperature for 30 minutes with non-shocked (NS-18oC) or heat shocked (HS-33oC for
1hour) oocyte extracts and no antibody (lanes 1 and 2) or antibodies against PP5 (lanes
3 and 4) and FKBP52 (lanes 7 and 8).  Lanes 5 and 6 (PP5 and FKBP52) and lanes 9
and 10 (FKBP52 and PP5) were incubated as above with the antibody listed first and
then incubated with the second antibody for another 30 minutes at room temperature.
All samples were electrophoresed on an acrylamide gel and HSF1-HSE complexes
were detected (labelled HSF1, HSF1+Ab, or HSF1++Ab).  All experiments were





 1       2      3      4      5      6       7      8      9    10
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present in the HSF1 heterocomplex.  In order to determine if both proteins are present
within the complex simultaneously, PP5 antibody was added to the binding reaction
followed by the addition of an FKBP52 antibody (lane 6).  The reciprocal experiment
was also done where the addition of PP5 antibody followed the addition of the FKBP52
antibody (lane 10).  The addition of a second antibody resulted in further retardation of
the HSF1-HSE complex (lanes 6 and 10) when compared to the migration observed
when only a single antibody was used in the reaction (lanes 4 and 8).  The additional
retardation brought about by sequential addition of the respective antibodies suggest
that both PP5 and FKBP52 may be present in the heterocomplex at the same time.  If
this is indeed true and both proteins are present in the heterocomplex simultaneously,
then PP5 may bind directly to HSF1 or a member of the heterocomplex other than
HSP90, as previous studies have already shown that FKBP52 binds the complex via the
TPR domain of HSP90.  These results further support the hypothesis that PP5 may bind
the HSF1 heterocomplex independently of HSP90.
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5.0  DISCUSSION
The major finding of this thesis is that PP5 is a component of the HSF1-HSP90
heterocomplex, serving as a negative-regulator of DNA binding and transcriptional
activation.
In this thesis I utilized the Xenopus oocyte model system to test the hypothesis
that PP5 regulates the DNA binding and transcriptional activities of HSF1.  The
experimental approach taken was to manipulate the level of PP5 activity within the
oocyte and determine the subsequent effects on HSF1 activities.  To elevate
intracellular PP5 phosphatase activity, expression vectors encoding PP5 or the HSP90
C-terminal region known to stimulate PP5, were microinjected into oocytes serving
either to increase PP5 protein levels or to elevate the activity of endogenous PP5.  PP5
was also inhibited using immunotargetting experiments and by treating oocytes with
okadaic acid.  As well, I attempted to determine if PP5 interacts with the HSF1
heterocomplex using a combination of gel mobility supershift assays and
immunoprecipitations.  Thus together, the results presented in this thesis provide
evidence that PP5 interacts with the HSF1 heterocomplex and functions to negatively
regulate the DNA binding and transcriptional activities of HSF1.
It has been hypothesized that the chaperone machinery required for GR
assembly may be similar to that involved in the regulation of HSF1 (Nair et al., 1996).
Using the Xenopus model system, Ali et al., (1998) and Bharadwaj et al., (1999)
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confirmed that the chaperones involved in GR maturation resemble those present in the
chaperone heterocomplex regulating the activities of HSF1.  Interestingly, several
studies have identified PP5 as a member of the chaperone complex involved in the
maturation and activation of GRs.  For example, Dean et al., (2001) demonstrated that
in the absence of PP5, shuttling of GRs from the nucleus to the cytoplasm ceases,
resulting in the nuclear accumulation of GRs and increased GR-DNA binding.  Two
contradicting studies have also shown that the inhibition of PP5 can result in either an
increase or decrease in GR-mediated transcription (Chen et al., 1996; Zuo et al., 1999).
As well, PP5 has recently been found to interact with the HSF1 heterocomplex (Guo et
al., 2001), however no studies prior to this one had examined what role PP5 may play
in the regulation of HSF1.
5.1  The Subcellular Localization of PP5
It has been established that HSF1 exists in the nucleus of Xenopus oocytes both
under non-shock and heat stress conditions (Mercier et al., 1997).  Therefore in order to
examine a possible role for PP5 in the regulation of HSF1, I wanted to determine the
subcellular localization of PP5.  Previous studies have identified PP5 as both a nuclear
and cytoplasmic protein in mammalian cells, but the subcellular localization of PP5 in
Xenopus oocytes has not previously been examined.  Using Western blot analysis on
manually dissected oocyte fractions, I determined that PP5 is both a cytoplasmic and
nuclear protein in Xenopus oocytes (figure 1).  It should be noted that although the
majority of PP5 appeared to be present in the cytoplasm, in this assay, the total protein
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mass of the cytoplasmic fraction is much greater than that of the nuclear fraction
therefore, there is actually more PP5 present in the nucleus than the results of the
Western blot would suggest.  It was determined that PP5 is a nuclear protein before and
after heat shock and that it appears to undergo translocation in response to heat
treatment (figure 1).  Consequently, it is possible that PP5 has the potential to interact
with and regulate the activities of HSF1 under both non-shock and heat shock
conditions.  For example, since PP5 is present in the nucleus before heat shock, it is
possible that PP5 regulates the DNA binding and transcriptional activities of HSF1 by
suppressing the formation of HSF1 trimers prior to heat shock.
Interestingly, PP5 has been identified as both a member of cytoplasmic and
nuclear GR complexes and was found to play a key role in the nucleocytoplasmic
shuttling of GRs (Dean et al., 2001).  Since HSF1 is a purely nuclear protein in
Xenopus oocytes, the reason for the translocation of PP5 can only be speculated.  One
possibility is that PP5 translocates with other members of the molecular chaperone
complex required to repress HSF1-DNA binding and HSF1 transcriptional activation.
For example, our lab has previously shown that HIP, HOP, and the immunophilin
FKBP52 translocate from the cytoplasm to the nucleus in heat shocked oocyte extracts
(Bharadwaj et al., 1999).  Although interactions between PP5 and these proteins have
not been investigated as of yet, HOP and FKBP52 each contain at least 3 TPR domains
belonging to the HSP90-family of TPR domains and therefore may have the potential to
interact with PP5 (Honore et al., 1992; Ratajczak et al., 1993; Kieffer et al., 1993;
Owens-Grillo et al., 1996).  Another possible reason as to why PP5 undergoes
translocation after heat shock is that the additional nuclear PP5 may be required to
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regulate the attenuation of HSF1.  For example, PP5 could function to either increase
the rate of trimer disassembly and promote HSF1 attenuation or further suppress the
formation of HSF1 trimers.  However, it has not been determined why the translocation
of PP5 occurs after heat shock in Xenopus oocytes as this is the first study examining
the role of PP5 as a regulator of HSF1 using this model system.
5.2  The Role of PP5 in HSF1 Oligomerization
The first major conclusion of these experiments is that PP5 regulates the DNA
binding activity of HSF1 either by suppressing the conversion of HSF1 monomers into
trimers or by promoting the disassembly of trimers.  This could occur both during the
induction and recovery phases of the heat shock response.  The gel mobility shift assays
performed throughout this thesis provide an indirect but efficient method of measuring
the oligomeric status of HSF1 since it is known that HSF1 only binds the HSE after it
has undergone trimerization, and that increases seen in HSF1-HSE binding are a direct
result of HSF1 trimer assembly in response to stress (reviewed by Lis and Wu, 1993).
Thus the formation of HSF1-HSE complexes are a direct reflection of the formation of
HSF1 trimers.  It has also been determined that HSF1 protein levels do not increase or
decrease in response to heat shock (figure 3), therefore in these experiments, any
changes seen in HSF1-DNA binding were due to the various treatments (increased PP5
levels, phosphatase inhibition) in the oocytes.
PP5 appears to function as a protein that represses HSF1-DNA binding, and hence
trimer formation.  In all experiments, activation of endogenous PP5 or elevation of PP5
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protein levels using microinjected expression vectors, consistently resulted in a
decrease in HSF1-HSE complex formation during the induction and recovery stages of
heat shock (figures 2, 3, and 8).  The decreased levels of HSF1-HSE binding
demonstrate that after heat shock, lower levels of HSF1 trimers are present in oocytes
containing activated or elevated levels of PP5 when compared to control, uninjected
oocytes.  This suggests that PP5 may suppress the DNA binding activity of HSF1 by
two possible mechanisms.  The first possibility is that PP5, through the
dephosphorylation of HSF1 itself or components of the HSF1-HSP90 heterocomplex,
inhibits trimerization or stabilizes the monomeric state of HSF1.  Interestingly,
inhibition of PP5 activity by immunotargeting or treatment of oocytes with okadaic
acid, had no apparent effect on the magnitude of trimer formation during the induction
stage of heat shock (figure 4).  Since PP5 appears to repress the trimerization of HSF1,
it might have been expected that the inhibition of PP5 activity would increase the
amount of trimers formed during heat shock.  However, this did not occur and is most
likely due to the fact that at maximal or optimal stress conditions used in these
experiments (33oC in Xenopus oocytes), all of the HSF1 present within the nucleus
trimerizes and additional HSF1-HSE binding could not be observed (DiDomenico et
al., 1982; Mosser et al., 1988; Strauss et al., 1990; Abrayava et al., 1991; Gordon et al.,
1997).  Therefore, an increase in HSF1 trimer formation was not observed when PP5
was inhibited even though this presumably functioned to promote the formation of
HSF1 trimers.
It also might have been expected that the inhibition of PP5 would have promoted
the formation of trimers independently of heat shock in the absence of stress, and that
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HSF1-HSE complexes would have been detected in non-shocked okadaic acid treated
oocytes.  This was not observed (figures 5 and 8), but HSF1-HSE binding in the
absence of stress was detected in attenuation studies where PP5 was inhibited by
immunotargeting accomplished through injection of PP5 antibodies.  Therefore it
remains possible that PP5 may regulate HSF1 by suppressing trimer formation (figure
8.B).  However, since DNA binding was not induced in all non-shocked oocytes
containing inhibited PP5, it is more likely that PP5 promotes the disassembly of HSF1
trimers and that the diminished amount of HSF1-HSE complexes seen in these
experiments was due to an increased rate of trimer disassembly rather than a decreased
rate of trimer assembly.
The most likely mechanism by which PP5 acts to reduce the level of HSF1-HSE
trimers is by accelerating the rate at which HSF1 trimers are converted into inactive
monomers, as elevated levels of PP5 phosphatase activity decreased the detectable level
of HSF1-HSE complex formation (figure 2, 3, and 7).  It follows that if PP5 were
inhibited, then a delay in HSF1 timer disassembly and therefore prolonged HSF1-HSE
binding would be observed in cells recovering from heat shock.  Attenuation studies
performed on oocytes containing inhibited PP5 activity indeed resulted in prolonged
retention of HSF1-HSE complexes after removal from heat shock conditions (for at
least 15 minutes longer) (figure 8).
It has been determined that the level and activation of HSF1-DNA binding and
HSF1-mediated transcription varies according to the type of stress.  For example,
salicylate has been shown to induce the formation of HSF1-HSE complexes without
inducing the transcriptional activation of HSF1 (Jurivich et al., 1992 and 1995).
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Therefore, since the activities of HSF1 vary according to the type of stress, it was
possible that the mechanisms of HSF1 regulation also vary and that PP5 may not
function to decrease HSF1-HSE binding in stresses other than heat shock.  To
determine what effect PP5 had if any on HSF1 trimer formation in stresses other than
heat shock, oocytes with increased levels of PP5 were treated with salicylate, arsenite,
cadmium, and ethanol (figure 6).  It was determined that elevation of PP5 indeed
decreased the amount of HSF1-HSE complex formation in salicylate; arsenite;
cadmium; and ethanol-treated oocytes to approximately the same degree as in heat
shock treated oocytes.  This suggests that PP5 may regulate the DNA binding activities
of HSF1 in a similar manner in response to a variety of stresses.  Again, in the case of
chemical stressors, it is possible that PP5 represses formation of trimers or promotes
trimer disassembly.
5.3  The Role of PP5 in HSF1-mediated Transcription
The second major conclusion of this thesis is that PP5 also acts to negatively
regulate the transcriptional activities of HSF1.  Several studies have demonstrated that
the transcriptional activation and DNA binding activities of HSF1 are separately
regulated (Hensold et al., 1990; Jurivich et al., 1992; Bharadwaj SHOE et al., 1999).
Therefore, it was possible that PP5 could inhibit or suppress HSF1-HSE complex
formation, but not affect the transactivation of HSF1.  Transcription assays using
reporter constructs were performed to test this (figure 10.A).  It was observed that
elevated levels of PP5 acted to significantly decrease or, in fact, completely repress
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HSF1-dependent transcription of the hsp70 promoter.  These results correlate well with
the HSF1-DNA binding studies demonstrating that elevation of PP5 decreases HSF1-
HSE complex formation (figures 2,3, and 7) and suggests that PP5 acts to negatively
regulate HSF1-DNA binding as well as HSF1 transcriptional activation. It is possible
that PP5 affects both the DNA binding and transcriptional activities of HSF1 by
repressing the formation of HSF1 trimers however, because the degree of
transcriptional inhibition (no hsp70 promoter activity) is much greater than that
observed in DNA binding reduction (approximately 2-3 fold), it is possible that PP5
functions not only to inhibit the formation of HSF1 trimers, but also to inhibit the
transcriptional activation domain of any HSF1 trimers that do form in oocytes
containing elevated levels of PP5.
Oocytes that were treated with okadaic acid showed results similar to those found
in HSF1-HSE binding assays; inhibition of PP5 did not result in increased HSF1-
mediated transcription (figures 4 and 8).  Although PP5 inhibition was shown to
prolong the attenuation of HSF1-DNA binding (figure 8), this did not enhance hsp70
promoter activity and could again suggest that PP5 may regulate HSF1-DNA binding
differently than HSF1 transactivation as the two events are separately regulated.
It was also necessary to determine if the effects seen on HSF1 transactivation
were due specifically to the activities of PP5 and not that of other protein phosphatases.
Experiments in which PP1 enzyme levels were increased in oocytes demonstrated that
this phosphatase had no significant effect on HSF1 transcriptional activation (figure
10.A).  This was consistent with experiments demonstrating that PP1 had no effect on
HSF1-HSE binding (figures 5 and 9).  Interestingly, it was found that increased levels
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of PP2A resulted in a significant decrease in hsp70 promoter activity (figure 10.A).
The converse was true when PP2A was inhibited using fostriecin, since enhanced
transcriptional activity.  Previous experiments indicated that these treatments had a
minor effect on HSF1-HSE binding, therefore it may be that PP2A acts to regulate
HSF1 at the level of DNA binding and transactivation or that PP2A stimulates the
phosphatase activity of PP5 in vivo and indirectly inhibits the activities of HSF1.
Although it has been established that PP2A and PP5 interact in vitro, it has not been
determined if PP2A regulates the activities of PP5 in vivo.  It remains possible that
PP2A itself effects the transactivation and DNA binding of HSF1.  Ding et al., (1998)
observed previously that the phosphatase activity of PP2A was elevated in cells
overexpressing HSP70, and suggested that PP2A may function to dephosphorylate
HSF1 and negatively regulate its transcriptional activities.  However, no further studies
have been performed to determine how PP2A may regulate HSF1.  Future studies
should be carried out using PP1 and PP2A expression vectors and additional inhibitors
to investigate exactly how PP2A may regulate HSF1-HSE binding and HSF1
transcriptional activation.
It has been demonstrated that stresses other than heat shock activate HSF1-DNA
binding but not HSF1-mediated transcription.  Bharadwaj et al., (1999) showed in
Xenopus oocytes that cadmium chloride activates both the DNA binding and
transcriptional activities of HSF1.  It is important to note that in Xenopus oocytes, not
all stresses capable of activating HSF1-HSE binding activate HSF1 dependent
transcription (Bharadwaj et al., 1999).  Cadmium was the only stress used other than
heat shock that activates HSF1 transcriptional activity (Bharadwaj et al., 1999).
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Transcription assays illustrated that elevated PP5 protein levels decreased the
transcriptional activity of HSF1 in response to cadmium (figure 10.B).  Thus the
inhibitory effect of PP5 on transcription is not restricted to heat shock.
5.4  PP5 interactions with HSF1
Previous studies have identified PP5 as a member of the GR-HSP90
heterocomplex that regulates the maturation and activation of GRs (Chen et al., 1996;
Silverstein et al., 1997; Zuo et al., 1999; Dean et al., 2001).  It has been well
established that the chaperone complex associated with the regulation of HSF1 shares
many similar structural and functional features with the heterocomplexes that regulate
GRs (Ali et al., 1998; Zuo et al., 1999; Bharadwaj et al., 1999).  This gave rise to the
hypothesis that PP5 may interact with and somehow regulate the DNA binding and
transcriptional activities of HSF1 in Xenopus oocytes.  Guo et al., (2001) have recently
shown, using tissues culture cells and immunoprecipitation experiments, that PP5
interacts with the HSF1 heterocomplex, although the function of PP5 within the
complex was not investigated.  This thesis has provided evidence that the phosphatase
activity of PP5 negatively regulates the DNA binding and transcriptional activation of
HSF1.  It is possible that PP5 exerts its effects on HSF1 through direct physical
interactions with the heterocomplex or indirectly, perhaps by removal of phosphate
groups from auxiliary regulating proteins.
Showing retardation of the HSF1-HSE complex with PP5 antibodies provided
evidence for a direct physical association between PP5 and HSF1 (figure 11.A).  Co-
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immunoprecipitations confirmed that PP5 interacts with HSF1 trimers and that PP5 also
interacts with the inactive monomeric form of HSF1 that exists under non-shock
conditions (figure 11.B).  Together these results strongly suggest that PP5 interacts with
the HSF1 heterocomplex during both non-shock and heat shock conditions.  These
results are consistent in all experiments performed throughout this thesis, and when
combined, indicate that PP5 negatively regulates the activities of HSF1 in vivo.  This
finding is significant because it sheds light on a potential mechanism for PP5 function
in the HSF1 heterocomplex.  Apparently, PP5 remains associated with HSF1 in
monomeric and trimeric states and the association of PP5 with HSF1 appears not to be
affected by heat shock since it co-immunoprecipitated equally in control and stressed
samples (figure 11.B).  Thus PP5 may function as a key regulatory phosphatase
throughout the activation/deactivation cycle of HSF1 before, during, and after stress.
PP5 has been shown to interact with GRs by binding to HSP90 through its TPR
domain, and immunoprecipitation studies suggest binding of an immunophilin or PP5
to the GR complex is mutually exclusive.  One could suggest then, that if PP5 interacts
with the HSF1 heterocomplex via similar HSP90-TPR dependent binding, it should
exert its regulatory effects on HSF1 dependent on HSP90, and might not co-exist
within the heterocomplex along with one of the immunophilins.  However, supershift
assays indicate that both PP5 and FKBP52 are present in HSF1 complexes
simultaneously (figure 14).  Since several studies involving GR complexes have shown
that these two proteins compete for binding to HSP90 and display exclusive binding to
GR-HSP90 complexes, the results shown here suggest that PP5 interacts differently
with HSF1-HSP90 heterocomplexes.  It is possible that PP5 binds the heterocomplex at
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a different location than immunophilins, therefore, unlike the immunophilins, PP5 may
exist within the HSF1 heterocomplex throughout the activation and deactivation cycle.
Indeed, co-immunoprecipitation experiments showed that PP5 interacts with both the
monomeric and trimeric forms of HSF1.
To further investigate how PP5 may bind the HSF1 heterocomplex, expression
vectors encoding PP5 mutants unable to bind HSP90 were microinjected into oocytes.
Increased levels of the mutated forms of PP5 were still able to exert similar repressive
effects on HSF1-HSE complex formation as wild-type PP5, since reduced levels were
seen during both the induction and recovery stages of heat shock (figure 12) and
suggests that PP5 may act to decrease HSF1-HSE binding independent of its ability to
bind HSP90. Transcription assays using reporter constructs also illustrated that the PP5
mutants, similarly to wild-type PP5, decreased HSF1-mediated transcription (figure
14).  This could suggest that unlike in GR regulation, PP5 interacts with HSF1 directly
or with heterocomplex members other than HSP90.  It is possible though that the
findings observed are the result of PP5 mutants exerting phosphatase activity on HSF1-
HSP90 complexes independently of direct stable binding as the PP5 mutants may retain
the ability to interact with Xenopus HSP90, however this is unlikely as HSP90 is a
highly conserved protein.  A third possibility is that the PP5 exerts its effects on HSF1
independently of being bound to an existing HSF1 heterocomplex.  Again however this
is probably unlikely as immunoprecipitation and supershift assays experiments have
indicated that PP5 interacts with the HSF1 heterocomplex (figure 11.A and B).
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Unfortunately, it was not possible to directly assess the interactions of the PP5 mutants
with the HSF1 complex (using supershift or immunoprecipitation assays), because there
was no way to distinguish the mutated forms of PP5 from endogenous PP5 using
antibodies.  Future experiments may include performing an immunoprecipitation with
PP5 and HSP90 to further determine how PP5 may bind the HSF1-HSP90
heterocomplex.
5.5  Mechanisms of HSF1 Regulation by PP5
Many studies suggest that phosphorylation events regulate HSF1 at the level of
DNA binding and transcriptional activation.  However, the mechanisms and sequences
of phosphorylation/dephosphorylation events remain unclear, and the majority of the
previous research has focused on how hyperphosphorylation might regulate the
transactivation of HSF1.  HSF1 remains transcriptionally inert through constitutive
phosphorylation and HSF1 transcriptional activation is associated with
hyperphosphorylation (Sorger et al., 1987; Sorger and Pelham, 1988; Baler et al., 1993;
Sarge et al., 1993).  Subsequent studies have since identified specific residues, such as
serine 230, 303, 307, and threonine 142, that must be inducibly phosphorylated for full
transcriptional activation of HSF1 (Holmberg et al. 2001; Soncin et al., 2003;
Hietakangas et al., 2003).  Conversely, several studies have illustrated that the
constitutive or inducible phosphorylation of HSF1 acts to repress HSF1 transcriptional
activities.  Phosphorylation of serines 303, 307, and 363 have all been shown to repress
the transcriptional activation of HSF1 (Chu et al., 1996 and 1998; Kline and Morimoto,
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1997).  It has also been demonstrated that HSF1 transactivation is repressed when the
enzyme level of several kinases such as MAPK, PKC, and GSK3 b  are increased (Chu
et al., 1996 and 1998; Xavier et al., 2000).  Except for the observations by Ding et al.,
(1998) that suggest the activities of PP1 and PP2A increase in response to elevated
HSP70 protein levels, none of the previous studies have identified a phosphatase that
might be responsible for the regulation of HSF1.
The results presented in this thesis demonstrate that PP5 negatively regulates both
HSF1-HSE complex formation and HSF1 transactivation.  Since previous studies have
shown that serines 230, 303, and 307, and threonine 142 become hyperphosphorylated
on transcriptionally active HSF1, and since elevated levels of PP5 were shown to
decrease the level of HSF1-mediated transcription, it is possible that PP5 may exert its
regulatory effects on HSF1 by dephosphorylating one or more of these residues.
Phosphorylation of threonine 142 may also be required for the efficient binding of
HSF1 to the HSE (Soncin et al., 2003).  Therefore, since a decrease in HSF1 complex
formation was seen in oocytes containing activated or elevated levels of PP5, it could
be that PP5 specifically dephosphorylates threonine 142 and negatively regulates the
DNA binding activities of HSF1.  From the current data, the precise mechanism by
which PP5 regulates the DNA binding and transcriptional activities of HSF1 is not yet
known.
In summary, it has been shown that PP5 interacts with both the monomeric and
trimeric forms of HSF1 before and after heat shock, that activated or increased levels of
PP5 decrease both the level of HSF1-HSE complex formation and HSF1
transactivation, and that cells containing inhibited PP5 result in prolonged HSF1-HSE
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APPENDIX 1.  Structure of HSF1
Appendix 1:  Structure of human heat shock transcription factor 1 (HSF1).  HSF1 is
composed of three major domains, a DNA binding domain (DBD), a regulatory domain
(RD), and a transcriptional activation domain (TAD).  HSF1 also contains two heptad
repeat regions (HR-A/B and HR-C) that are involved in the regulation of HSF1
trimerization.
DBD  HR-A/B   HR-CN C
  1       16                  123    137            212                         384       417                 529
RD                          TAD
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APPENDIX 2.  Structure of PP5
Appendix 2:  The structure of human protein phosphatase 5 (PP5).  PP5 is composed of
three tetratricopeptide repeat domains (TPR) labelled 1, 2, and 3, a catalytic domain
(CD), and a C terminal regulatory domain (RD).
N C1      2      3                                 CD                         RD
 TPR
